Cardiovascular disease manifests predominantly as myocardial ischemia, heart failure, stroke, aortic aneurysm, and peripheral vascular disease and leads to the majority of deaths and disabilities worldwide. Endothelial cells (ECs) constitute the inner lining of all blood vessels and form the interface between the circulation and the vascular wall ([@B1]). The endothelial monolayer is pivotal for maintaining vascular homeostasis through a balance of endothelium-derived factors ([@B2], [@B3]). ECs are preferred targets of cardiovascular risk factors such as hypercholesterolemia, diabetes, hypertension, and smoking ([@B1], [@B4]). Repetitive injury is associated with a varying degree of endothelial dysfunction. Alterations in its anticoagulant and anti-inflammatory properties leave the vasculature susceptible to disease ([@B5]) and play a key role in the initiation and progression of cardiovascular disease ([@B6]).

Previous proteomics studies ([@B7][@B8][@B9][@B10][@B11][@B12]--[@B13]), including one by our group ([@B8]), have investigated the secretome of unstimulated human umbilical vein ECs (HUVECs), the most widely used ECs in cardiovascular research. Only two studies have explored the secretome of HUVECs upon activation by shear stress ([@B10]) or with statin treatment ([@B13]) thus far. One study used human microvascular ECs ([@B9]), which represent a distinct population of ECs from small vessels. Yet many factors secreted by ECs were not identified, probably because of their low abundance. In this study, we used a secretagogue, phorbol ester phorbol-12-myristate-13-acetate (PMA) ([@B14], [@B15]), to induce maximal protein release from serum-starved HUVECs over 45 min. In addition, we applied three different proteomic strategies for the analysis of glycoproteins/glycopeptides to further enrich secreted proteins and characterize their glycosylation sites.

EXPERIMENTAL PROCEDURES
=======================

### 

#### EC Culture

HUVECs (Lonza Group Ltd., Basel, Switzerland) were cultured on 0.1% gelatin-coated flasks in M199 medium supplemented with 1 ng/ml endothelial cell growth factor (Sigma), 3 μg/ml endothelial growth supplement from bovine neural tissue (Sigma), 10 U/ml heparin, 1.25 μg/ml thymidine, 10% fetal bovine serum (A15--108, PAA Laboratories, Velizy-Villacoublay, France), and 100 μg/ml penicillin and streptomycin in a humidified incubator supplemented with 5% CO~2~ at 37 °C. The cells were subcultured every 2 to 3 days at a ratio of 1:4 ([@B16]).

#### Conditioned Medium Collection

HUVECs were cultured in complete medium until confluent. Then, they were washed and incubated in M199 medium for 30 min twice before stimulation with 50 n[m]{.smallcaps} PMA (Sigma) in M199 medium for 45 min. The control group was incubated with M199 medium in the absence of PMA for 45 min. Conditioned media were collected and stored at −80 °C for further analysis.

#### Immunofluorescence Staining

HUVECs were cultured in Nunc chamber slides (Sigma-Aldrich) for 3 days. HUVECs were stimulated with 50 n[m]{.smallcaps} PMA in M199 medium for 45 min or incubated with M199 medium for 45 min. The cells were fixed with 4% formaldehyde in PBS for 10 min, permeabilized with 0.1% Triton X-100 in PBS for 5 min, and blocked in 5% fetal bovine serum in PBS for 30 min at 37 °C. Following 1 h of incubation with the primary antibodies, VE-cadherin (ab33168, Abcam, Cambridge, UK), and von Willebrand factor (vWF) (sc-8068, Santa Cruz Biotechnology, Santa Cruz, CA) at 37 °C, an Alexa Fluor^®^ 594 conjugated donkey anti-rabbit IgG and an Alexa Fluor^®^ 488 conjugated donkey anti-goat IgG, respectively, were added, and the cells were incubated at 37 °C for 30 min. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (D9542, Sigma) for 5 min. The slide was mounted in fluorescence mounting medium (DAKO, Denmark A/S, Glostrup, Denmark) and examined with an AxioPlan 2 fluorescence microscope (Carl Zeiss, Thornwood, NY) ([@B17]).

#### Proteomics Profiling of the Secretome

Conditioned media were concentrated with an Amicon spin column (3kD MWCO, EDO Millipore Corp., Billerica, MA) and separated via 4%--12% Bis-Tris SDS-PAGE (Invitrogen). Proteins were visualized via silver staining (PlusOne silver staining kit for proteins, GE Healthcare). Gel bands were digested with modified trypsin (Promega Corp., Madison, WI) overnight on a ProGest digestion robot (Digilab Inc., Marlborough, MA) and analyzed via reverse-phase nano-flow HPLC (PepMap C18, 3 μm, 100 Å, 25 cm × 75 μm inner diameter column, Thermo Scientific) interfaced to an LTQ Orbitrap XL MS (Thermo Scientific) ([@B18]).

#### Deglycosylation

Concentrated media were mixed with deglycosylation buffer (150 m[m]{.smallcaps} NaCl, 50 m[m]{.smallcaps} sodium acetate, 10 m[m]{.smallcaps} EDTA, proteinase inhibitors, pH 6.8) supplemented with 0.05U PNGase F (Sigma), chondroitinase ABC (C3667, Sigma), and keratanase (G6920, Sigma) and incubated at 37 °C overnight ([@B19]).

#### Immunoblotting

Concentrated or deglycosylated media were separated via 4%--12% Bis-Tris gel (Invitrogen). Proteins were transferred on a nitrocellulose membrane and blocked with 5% bovine serum albumin in PBS. Membranes were incubated with primary antibody overnight at 4 °C. Secondary antibodies were incubated for 1 h at room temperature. After the addition of ECL (GE Healthcare), the film was developed using a Compact X4 Automatic Processor (Xograph Healthcare Ltd., Stonehouse, UK). The following primary antibodies were used: agrin (sc-25528, Santa Cruz Biotechnology), biglycan (ab54855, Abcam), connective tissue growth factor (sc-25440, Santa Cruz Biotechnology), fibronectin (sc-56391, Santa Cruz Biotechnology), and lymphatic vessel endothelial hyaluronic acid receptor 1 (AF2089, R&D Systems).

#### Difference Gel Electrophoresis

Conditioned media from HUVECs treated with or without PMA were concentrated using an Amicon spin column (3kD MWCO, Millipore) and the ReadyPrep 2D clean-up kit (Bio-Rad). The pellet was resuspended in difference gel electrophoresis lysis buffer (30 m[m]{.smallcaps} Tris, 8 [m]{.smallcaps} urea, 4% w/v CHAPS, protease inhibitors, pH 8.5). For each secretome sample, 15 μg of proteins were labeled with Cy3 or Cy5. A dye swap was performed to exclude preferential labeling. Cellular extracts of HUVECs were labeled with Cy2. Cy2-, Cy3-, and Cy5-labeled samples were separated via isoelectric focusing on immobilized pH gradient dry strips (18 cm, pH 3--10 NL, GE Healthcare) with 30 KVH. The strips were equilibrated with 10 mg/ml DTT in equilibration buffer (6 [m]{.smallcaps} urea, 2% w/v SDS, 30% v/v glycerol, 50 m[m]{.smallcaps} Tris, pH 8.8) for 15 min followed by 48 mg/ml iodoacetamide in equilibration buffer for 15 min before separation via SDS-PAGE at 100 W for 4 h using an Ettan DALTsix vertical electrophoresis system (GE Healthcare) ([@B20][@B21]--[@B22]). Gels were scanned on an Ettan difference gel electrophoresis imager (GE Healthcare). Images were overlaid with ImageQuant TL software (GE Healthcare). Common spots present in both the cellular proteome and the secretome were excised, digested with trypsin, and identified using nano-flow HPLC-MS/MS. Detailed protocols are available on our research group\'s website.

#### Glycopeptide Enrichment

Conditioned media were desalted via the use of Zeba spin columns (Thermo Scientific). Proteins were then reduced by 5 m[m]{.smallcaps} DTT and alkylated with 25 m[m]{.smallcaps} iodoacetamide. After acetone precipitation overnight, the pellet was resuspended in 100 m[m]{.smallcaps} triethylammonium bicarbonate (pH 8.5, Sigma) and digested with modified trypsin (Promega) at 37 °C overnight. Peptides were labeled at a ratio of 100 μg peptides/0.8 mg Tandem Mass Tag Zero (TMT^0^) (Thermo Scientific) according to the manufacturer\'s instruction. Labeled peptides were further enriched for glycopeptides using zwitterionic hydrophilic interaction liquid chromatography resin (Merck) ([@B23]).

#### LC/MS of Intact Glycopeptides

The glycopeptide enriched fraction was separated using the EASY-nLC^TM^ nano-HPLC system (Thermo Scientific) with a Magic C18 spray tip 15 cm × 75 μm inner diameter column (Bruker-Michrom, Auburn, CA). Gradient elution was performed with 4% to 30% acetonitrile in 0.1% formic acid over 60 min at a flow rate of 300 nl/min. The samples were analyzed with an Orbitrap Elite hybrid MS with electron-transfer dissociation (ETD) (Thermo Scientific). The following MS and MS/MS settings were used: Fourier transform: MSn automatic gain control target = 5E4; MS/MS = 1 μscans, max ion time = 200 ms; MS = 300--1800 *m*/*z*, resolution = 60,000 at *m*/*z* 400, MS target = 1E6; dynamic exclusion = repeat count 1, duration 30 s, exclusion duration 90 s; higher-energy C-trap dissociation (HCD): collision energy = 35%, resolution = 15,000; MSn target ion trap = 1E4, 2 μscans, max ion time = 150 ms; ETD anion automatic gain control target = 2E5, charge-dependent ETD reaction time enabled. For alternating HCD-ETD MS/MS, the top 10 ions were analyzed. For HCD-product-dependent ETD, the top 10 ions were analyzed via HCD, and product-dependent ETD acquisition was triggered by product (oxonium) ions (*m*/*z* 163.0812 for Hex; *m*/*z* 204.0864 for HexNAc; *m*/*z* 138.0554 for HexNAc fragment ion) ([@B24]).

#### Deglycosylation with PNGase F and H~2~^18^*O*

Zwitterionic hydrophilic interaction liquid chromatography resin enriched glycopeptides were resuspended in 50 m[m]{.smallcaps} ammonium bicarbonate in H~2~^18^O (97 atom % ^18^O, Sigma) and deglycosylated with PNGase F (Sigma) for 4 h at 37 °C. The samples were separated via reverse-phase nano-flow HPLC (PepMap C18, 3 μm, 100 Å, 25 cm × 75 μm inner diameter column, Thermo Scientific) before analysis on an LTQ Orbitrap XL MS (Thermo Scientific).

#### Glycoprotein Enrichment and LC/MS

ConA[^1^](#G1){ref-type="fn"} lectin resins (Thermo Scientific) were used to enrich glycoproteins from concentrated conditioned media according to the manufacturer\'s protocol. The input, glycoprotein-enriched fraction, and flow-through samples were subjected to trypsin digestion. The in-solution digests were separated on a Thermo Scientific Dionex UltiMate 3000 Rapid Separation LC (RSLC) system using a PepMap C18 column (3 μm, 100 Å, 50 cm × 75 μm inner diameter column, Thermo Scientific). The rapid separation LC system was interfaced to a Q Exactive MS (Thermo Scientific), and samples were analyzed using a top-10 HCD method.

#### Database Search and Data analysis

The following parameters were used for different experiments.

\(i\) Gel-LC-MS/MS: Peak lists were generated by Mascot daemon (version 2.3.0, Matrix Science Ltd., London, UK) using extract_msn_com.exe and searched against the UniProt/Swiss-Prot mammalian database (version 2012.03, 65,780 entries) using Mascot (version 2.3.01, Matrix Science) with peptide tolerance = 10 ppm, MS/MS tolerance = 0.8 Da, carbamidomethylation of cysteine as a fixed modification, oxidation of methionine as a variable modification, and a maximum of two missed cleavage sites. The search results were loaded into Scaffold software (version 3.6.2, Proteome Software Software, Inc., Portland, OR). A protein probability greater than 99%, a peptide probability greater than 95%, and a minimum number of two peptides per protein were applied as filters to generate the protein list. Bovine contaminant proteins are listed separately.

\(ii\) PNGase F + H~2~^18^O experiment: Thermo Scientific Proteome Discoverer software version 1.3 was used to search against the UniProt/Swiss**-**Prot mammalian database (version 2012.03) using Mascot (version 2.3.01, Matrix Science) with a peptide tolerance of 10 ppm; an MS/MS tolerance of 0.8 Da; carbamidomethylation of cysteine as a fixed modification; oxidation of methionine, TMT^0^ label on lysine and peptide N-terminus, and deamidation (spontaneous deamidation in ordinary water) and O^18^-deamidation (deglycosylation by PNGase F in H~2~^18^O) of asparagine as variable modifications; and a maximum of two missed cleavage sites. Proteome Discoverer produced a custom database containing 136 target proteins based on this search.

\(iii\) Orbitrap Elite MS: Raw files were searched against the 136-protein database (along with reversed proteins as decoys) using Byonic^TM^ ([@B25]) with a peptide tolerance of 10 ppm; an MS/MS tolerance of 20 ppm for HCD and 0.6 Da for ETD; the carbamidomethylated cysteine, TMT^0^ label on lysine and peptide N-terminus as fixed modifications; and oxidation of methionine, deamidation of asparagine and glutamine, and phosphorylation of serine and threonine as variable modifications. Byonic^TM^ allowed one N-glycan modification on the N-X(not P)-S/T consensus motif per peptide, with mass and composition chosen from its "common human" glycan database containing 350 glycan masses up to 6000 Da. Glycan modifications were verified by the presence of corresponding glycan fragment ions, such as the HexNAc oxonium ion at 204.087 Da in HCD spectra. Peptide sequences were identified by Byonic^TM^ from the ETD spectra and verified manually.

\(iv\) Q Exactive MS: Raw files were searched against the UniProt/Swiss-Prot human database (version 57.13, 20,266 entries) using Proteome Discoverer (version 1.3, Thermo Scientific) with Mascot (version 2.3.0, Matrix Science) and a peptide tolerance of 10 ppm, an MS/MS tolerance of 10 mmu, carbamidomethylation of cysteine as a fixed modification, oxidation of methionine as a variable modification, and a maximum of two missed cleavage sites.

RESULTS
=======

### 

#### The Secretome of Activated ECs

HUVECs were stimulated with PMA, a commonly used secretagogue that induces exocytosis of endothelial vesicles. As previously reported ([@B26]), the morphology of ECs changes from spindle-shaped to round upon PMA activation, and the rod-shaped Weibel-Palade bodies, unique storage vesicles within ECs containing vWF and many other secreted proteins, fuse with the cell membrane ([Fig. 1](#F1){ref-type="fig"}*A*). In total, the secretomes of 17 primary ECs were analyzed via gel-LC-MS/MS, with or without deglycosylation. Apart from 123 secreted proteins, the conditioned medium of PMA-stimulated ECs was particularly rich in surface antigens and receptors, including many established endothelial markers ([Table I](#TI){ref-type="table"}). All identified proteins and peptides are listed in [supplemental Tables S1 and S2](http://www.mcponline.org/cgi/content/full/M112.024018/DC1), respectively. The distribution of the frequencies and the cumulated distribution of the number of samples in which proteins were identified are shown in [supplemental Fig. S1](http://www.mcponline.org/cgi/content/full/M112.024018/DC1). MS datasets of three biological replicates have been deposited in PRIDE (accession numbers 26908--27003).

![**PMA treatment to stimulate EC secretion.** Treatment of HUVECs with PMA, a commonly used secretagogue, resulted in a characteristic morphological change indicative of activation. *A*, immunofluorescence staining of vWF (green) and VE-cadherin (red) shows the exocytotic effect of PMA. *B*, PMA increased protein secretion in the conditioned media as confirmed via immunoblotting. *C*, relative to previous studies, more than twice as many secreted and plasma membrane proteins were identified. *D*, overlay of intracellular and secreted proteins by means of difference gel electrophoresis. In the left-hand panel, proteins in conditioned media of HUVECs are stained in green (+PMA) and red (−PMA), and cellular proteins are stained in blue. Results were reproduced with different biological replicates using reverse-labeling (right-hand panel: red, +PMA; green, −PMA). The protein corresponding to von Willebrand antigen 2 is highlighted with a box. Common proteins in the secretome and the cellular proteome are numbered in [supplemental Fig. S2](http://www.mcponline.org/cgi/content/full/M112.024018/DC1) and listed in [supplemental Table S3](http://www.mcponline.org/cgi/content/full/M112.024018/DC1).](zjw0041344130001){#F1}

###### Extracellular and plasma membrane proteins identified in the HUVEC-conditioned media after PMA stimulation

  Protein name                                                                                       UniProt ID    UniProt accession number   Gene name   Cellular component   Glycoprotein      EC marker      
  -------------------------------------------------------------------------------------------------- ------------- -------------------------- ----------- -------------------- ----------------- -------------- -----------
  Calcium ion-binding proteins                                                                                                                                                                                  
      Annexin A1                                                                                     ANXA1_HUMAN   [P04083](P04083)           ANXA1                            Plasma membrane                  
      Annexin A2**[*^a^*](#TFI-1){ref-type="table-fn"}**                                             ANXA2_HUMAN   [P07355](P07355)           ANXA2       Extracellular        Plasma membrane                  
      Annexin A3                                                                                     ANXA3_HUMAN   [P12429](P12429)           ANXA3                            Plasma membrane                  
      Calreticulin                                                                                   CALR_HUMAN    [P27797](P27797)           CALR        Extracellular                          Glycoprotein   
      Calumenin                                                                                      CALU_HUMAN    [O43852](O43852)           CALU        Extracellular                          Glycoprotein   
      Calpain-1 catalytic subunit                                                                    CAN1_HUMAN    [P07384](P07384)           CAPN1                            Plasma membrane                  
      Calpain-2 catalytic subunit                                                                    CAN2_HUMAN    [P17655](P17655)           CAPN2                            Plasma membrane                  
      Calpain small subunit 1                                                                        CPNS1_HUMAN   [P04632](P04632)           CAPNS1                           Plasma membrane                  
      Calsyntenin-1                                                                                  CSTN1_HUMAN   [O94985](O94985)           CLSTN1                           Plasma membrane   Glycoprotein   
      Calsyntenin-3                                                                                  CSTN3_HUMAN   [Q9BQT9](Q9BQT9)           CLSTN3                           Plasma membrane   Glycoprotein   
      Desmoglein-1                                                                                   DSG1_HUMAN    [Q02413](Q02413)           DSG1                             Plasma membrane   Glycoprotein   
      Nucleobindin-2                                                                                 NUCB2_HUMAN   [P80303](P80303)           NUCB2       Extracellular                                         
  Carbohydrate and glycan metabolism                                                                                                                                                                            
      Alpha-amylase 1                                                                                AMY1_HUMAN    [P04745](P04745)           AMY1C       Extracellular                          Glycoprotein   
      Exostosin-like 2                                                                               EXTL2_HUMAN   [Q9UBQ6](Q9UBQ6)           EXTL2       Extracellular                          Glycoprotein   
      Polypeptide N-acetylgalactosaminyltransferase 1                                                GALT1_HUMAN   [Q10472](Q10472)           GALNT1      Extracellular                          Glycoprotein   
      Sialate O-acetylesterase                                                                       SIAE_HUMAN    [Q9HAT2](Q9HAT2)           SIAE        Extracellular                          Glycoprotein   
      UDP-N-acetylhexosamine pyrophosphorylase                                                       UAP1_HUMAN    [Q16222](Q16222)           UAP1                             Plasma membrane                  
  Coagulation and related proteins                                                                                                                                                                              
      Amyloid-like protein 2                                                                         APLP2_HUMAN   [Q06481](Q06481)           APLP2                            Plasma membrane   Glycoprotein   
      Multimerin-1                                                                                   MMRN1_HUMAN   [Q13201](Q13201)           MMRN1       Extracellular                          Glycoprotein   
      Plasminogen activator inhibitor 1                                                              PAI1_HUMAN    [P05121](P05121)           SERPINE1    Extracellular                          Glycoprotein   
      Plasminogen activator inhibitor 2                                                              PAI2_HUMAN    [P05120](P05120)           SERPINB2    Extracellular                          Glycoprotein   
      Tissue factor pathway inhibitor                                                                TFPI1_HUMAN   [P10646](P10646)           TFPI        Extracellular                          Glycoprotein   
      Tissue factor pathway inhibitor 2                                                              TFPI2_HUMAN   [P48307](P48307)           TFPI2       Extracellular                          Glycoprotein   
      Tissue-type plasminogen activator                                                              TPA_HUMAN     [P00750](P00750)           PLAT        Extracellular                          Glycoprotein   
      von Willebrand factor                                                                          VWF_HUMAN     [P04275](P04275)           VWF         Extracellular                          Glycoprotein   EC marker
  Extracellular matrix components and associated proteins                                                                                                                                                       
      Agrin                                                                                          AGRIN_HUMAN   [O00468](O00468)           AGRN        Extracellular                          Glycoprotein   
      Collagen alpha-2(IV) chain                                                                     CO4A2_HUMAN   [P08572](P08572)           COL4A2      Extracellular                          Glycoprotein   
      Collagen alpha-1(VI) chain                                                                     CO6A1_HUMAN   [P12109](P12109)           COL6A1      Extracellular                          Glycoprotein   
      Collagen alpha-1(XII) chain                                                                    COCA1_HUMAN   [Q99715](Q99715)           COL12A1     Extracellular                          Glycoprotein   
      Collagen alpha-1(XVIII) chain                                                                  COIA1_HUMAN   [P39060](P39060)           COL18A1     Extracellular                          Glycoprotein   
      EGF-containing fibulin-like extracellular matrix protein 1                                     FBLN3_HUMAN   [Q12805](Q12805)           EFEMP1      Extracellular                          Glycoprotein   
      Fibrillin-1                                                                                    FBN1_HUMAN    [P35555](P35555)           FBN1        Extracellular                          Glycoprotein   
      Fibrillin-2                                                                                    FBN2_HUMAN    [P35556](P35556)           FBN2        Extracellular                          Glycoprotein   
      Fibronectin                                                                                    FINC_HUMAN    [P02751](P02751)           FN1         Extracellular                          Glycoprotein   
      Hyaluronan and proteoglycan link protein 3                                                     HPLN3_HUMAN   [Q96S86](Q96S86)           HAPLN3      Extracellular                                         
      Laminin subunit alpha-4                                                                        LAMA4_HUMAN   [Q16363](Q16363)           LAMA4       Extracellular                          Glycoprotein   
      Laminin subunit beta-1                                                                         LAMB1_HUMAN   [P07942](P07942)           LAMB1       Extracellular                          Glycoprotein   
      Laminin subunit gamma-1                                                                        LAMC1_HUMAN   [P11047](P11047)           LAMC1       Extracellular                          Glycoprotein   
      Lysyl oxidase homolog 2                                                                        LOXL2_HUMAN   [Q9Y4K0](Q9Y4K0)           LOXL2       Extracellular                          Glycoprotein   
      Multimerin-2                                                                                   MMRN2_HUMAN   [Q9H8L6](Q9H8L6)           MMRN2       Extracellular                          Glycoprotein   
      Nidogen-1                                                                                      NID1_HUMAN    [P14543](P14543)           NID1        Extracellular                          Glycoprotein   
      Nidogen-2                                                                                      NID2_HUMAN    [Q14112](Q14112)           NID2        Extracellular                          Glycoprotein   
      Prolyl 3-hydroxylase 1                                                                         P3H1_HUMAN    [Q32P28](Q32P28)           LEPRE1      Extracellular                          Glycoprotein   
      Basement membrane-specific heparan sulfate proteoglycan core protein                           PGBM_HUMAN    [P98160](P98160)           HSPG2       Extracellular                          Glycoprotein   
      Biglycan                                                                                       PGS1_HUMAN    [P21810](P21810)           BGN         Extracellular                          Glycoprotein   
      Peroxidasin homolog                                                                            PXDN_HUMAN    [Q92626](Q92626)           PXDN        Extracellular                          Glycoprotein   
      SPARC                                                                                          SPRC_HUMAN    [P09486](P09486)           SPARC       Extracellular                          Glycoprotein   
      Target of Nesh-SH3                                                                             TARSH_HUMAN   [Q7Z7G0](Q7Z7G0)           ABI3BP      Extracellular                          Glycoprotein   
      Testican-1                                                                                     TICN1_HUMAN   [Q08629](Q08629)           SPOCK1      Extracellular                          Glycoprotein   
      Thrombospondin-1                                                                               TSP1_HUMAN    [P07996](P07996)           THBS1       Extracellular        Plasma membrane   Glycoprotein   
  Growth factors and related proteins                                                                                                                                                                           
      C-type lectin domain family 11 member A                                                        CLC11_HUMAN   [Q9Y240](Q9Y240)           CLEC11A     Extracellular                          Glycoprotein   
      Cysteine-rich motor neuron 1 protein                                                           CRIM1_HUMAN   [Q9NZV1](Q9NZV1)           CRIM1       Extracellular        Plasma membrane   Glycoprotein   
      Connective tissue growth factor                                                                CTGF_HUMAN    [P29279](P29279)           CTGF        Extracellular                          Glycoprotein   
      Protein CYR61, insulin-like growth factor-binding protein 10                                   CYR61_HUMAN   [O00622](O00622)           CYR61       Extracellular                                         
      Dickkopf-related protein 3                                                                     DKK3_HUMAN    [Q9UBP4](Q9UBP4)           DKK3        Extracellular                          Glycoprotein   
      Follistatin-related protein 1                                                                  FSTL1_HUMAN   [Q12841](Q12841)           FSTL1       Extracellular                          Glycoprotein   
      Hepatoma-derived growth factor                                                                 HDGF_HUMAN    [P51858](P51858)           HDGF        Extracellular                                         
      Insulin-like growth factor-binding protein 2                                                   IBP2_HUMAN    [P18065](P18065)           IGFBP2      Extracellular                          Glycoprotein   
      Insulin-like growth factor-binding protein 7                                                   IBP7_HUMAN    [Q16270](Q16270)           IGFBP7      Extracellular                          Glycoprotein   
      Latent-transforming growth factor beta-binding protein 1                                       LTBP1_HUMAN   [Q14766](Q14766)           LTBP1       Extracellular                          Glycoprotein   
      Latent-transforming growth factor beta-binding protein 2                                       LTBP2_HUMAN   [Q14767](Q14767)           LTBP2       Extracellular                          Glycoprotein   
      Neuronal growth regulator 1                                                                    NEGR1_HUMAN   [Q7Z3B1](Q7Z3B1)           NEGR1                            Plasma membrane   Glycoprotein   
  Immunity- and inflammation-related proteins                                                                                                                                                                   
      Amyloid beta A4 protein                                                                        A4_HUMAN      [P05067](P05067)           APP         Extracellular        Plasma membrane   Glycoprotein   
      Beta-2-microglobulin                                                                           B2MG_HUMAN    [P61769](P61769)           B2M         Extracellular                          Glycoprotein   
      Complement C1q tumor necrosis factor-related protein 5                                         C1QT5_HUMAN   [Q9BXJ0](Q9BXJ0)           C1QTNF5     Extracellular                                         
      Complement factor H                                                                            CFAH_HUMAN    [P08603](P08603)           CFH         Extracellular                          Glycoprotein   
      Interleukin-25, UPF0556 protein C19orf10                                                       CS010_HUMAN   [Q969H8](Q969H8)           C19orf10    Extracellular                                         
      Granulins                                                                                      GRN_HUMAN     [P28799](P28799)           GRN         Extracellular                          Glycoprotein   
      Interferon-induced transmembrane protein 1                                                     IFM1_HUMAN    [P13164](P13164)           IFITM1                           Plasma membrane                  
      Galectin-1[*^a^*](#TFI-1){ref-type="table-fn"}                                                 LEG1_HUMAN    [P09382](P09382)           LGALS1      Extracellular                                         
      Galectin-3                                                                                     LEG3_HUMAN    [P17931](P17931)           LGALS3      Extracellular                                         
      Macrophage migration inhibitory factor[*^a^*](#TFI-1){ref-type="table-fn"}                     MIF_HUMAN     [P14174](P14174)           MIF         Extracellular                                         
      NKG2D ligand 2                                                                                 N2DL2_HUMAN   [Q9BZM5](Q9BZM5)           ULBP2       Extracellular        Plasma membrane   Glycoprotein   
      Pentraxin-related protein PTX3                                                                 PTX3_HUMAN    [P26022](P26022)           PTX3        Extracellular                          Glycoprotein   
      Protein S100-A7                                                                                S10A7_HUMAN   [P31151](P31151)           S100A7      Extracellular                                         
      Protein S100-A8                                                                                S10A8_HUMAN   [P05109](P05109)           S100A8      Extracellular        Plasma membrane                  
      Tubulointerstitial nephritis antigen-like                                                      TINAL_HUMAN   [Q9GZM7](Q9GZM7)           TINAGL1     Extracellular                          Glycoprotein   
      Nuclease-sensitive element-binding protein 1                                                   YBOX1_HUMAN   [P67809](P67809)           YBX1        Extracellular                                         
      Zinc-alpha-2-glycoprotein                                                                      ZA2G_HUMAN    [P25311](P25311)           AZGP1       Extracellular                          Glycoprotein   
  Membrane antigens and receptors                                                                                                                                                                               
      HLA class I histocompatibility antigen, A-24 alpha chain                                       1A24_HUMAN    [P05534](P05534)           HLA-A                            Plasma membrane   Glycoprotein   
      HLA class I histocompatibility antigen, A-30 alpha chain                                       1A30_HUMAN    [P16188](P16188)           HLA-A                            Plasma membrane   Glycoprotein   
      HLA class I histocompatibility antigen, Cw-12 alpha chain                                      1C12_HUMAN    [P30508](P30508)           HLA-C                            Plasma membrane   Glycoprotein   
      Alpha-2-macroglobulin receptor-associated protein                                              AMRP_HUMAN    [P30533](P30533)           LRPAP1      Extracellular        Plasma membrane   Glycoprotein   
      Basal cell adhesion molecule                                                                   BCAM_HUMAN    [P50895](P50895)           BCAM                             Plasma membrane   Glycoprotein   
      Complement component C1q receptor                                                              C1QR1_HUMAN   [Q9NPY3](Q9NPY3)           CD93                             Plasma membrane   Glycoprotein   EC marker
      Cadherin-13                                                                                    CAD13_HUMAN   [P55290](P55290)           CDH13                            Plasma membrane   Glycoprotein   
      Cadherin-2                                                                                     CADH2_HUMAN   [P19022](P19022)           CDH2                             Plasma membrane   Glycoprotein   
      Cadherin-5                                                                                     CADH5_HUMAN   [P33151](P33151)           CDH5                             Plasma membrane   Glycoprotein   EC marker
      CD109 antigen                                                                                  CD109_HUMAN   [Q6YHK3](Q6YHK3)           CD109                            Plasma membrane   Glycoprotein   
      CD166 antigen                                                                                  CD166_HUMAN   [Q13740](Q13740)           ALCAM                            Plasma membrane   Glycoprotein   
      CD44 antigen                                                                                   CD44_HUMAN    [P16070](P16070)           CD44                             Plasma membrane   Glycoprotein   
      CD59 glycoprotein                                                                              CD59_HUMAN    [P13987](P13987)           CD59        Extracellular        Plasma membrane   Glycoprotein   
      CD9 antigen                                                                                    CD9_HUMAN     [P21926](P21926)           CD9                              Plasma membrane   Glycoprotein   
      C-type lectin domain family 14 member A                                                        CLC14_HUMAN   [Q86T13](Q86T13)           CLEC14A                          Plasma membrane   Glycoprotein   
      Dystroglycan                                                                                   DAG1_HUMAN    [Q14118](Q14118)           DAG1        Extracellular        Plasma membrane   Glycoprotein   
      Endoglin                                                                                       EGLN_HUMAN    [P17813](P17813)           ENG                              Plasma membrane   Glycoprotein   EC marker
      Endothelial protein C receptor                                                                 EPCR_HUMAN    [Q9UNN8](Q9UNN8)           PROCR                            Plasma membrane   Glycoprotein   EC marker
      Ephrin type-B receptor 4                                                                       EPHB4_HUMAN   [P54760](P54760)           EPHB4                            Plasma membrane   Glycoprotein   
      Endothelial cell-selective adhesion molecule                                                   ESAM_HUMAN    [Q96AP7](Q96AP7)           ESAM                             Plasma membrane   Glycoprotein   EC marker
      Leucine-rich repeat transmembrane protein FLRT2                                                FLRT2_HUMAN   [O43155](O43155)           FLRT2                            Plasma membrane   Glycoprotein   
      Guanine nucleotide-binding protein subunit beta-2-like 1[*^a^*](#TFI-1){ref-type="table-fn"}   GBLP_HUMAN    [P63244](P63244)           GNB2L1                           Plasma membrane                  
      HLA class I histocompatibility antigen, alpha chain E                                          HLAE_HUMAN    [P13747](P13747)           HLA-E                            Plasma membrane   Glycoprotein   
      Intercellular adhesion molecule 1                                                              ICAM1_HUMAN   [P05362](P05362)           ICAM1       Extracellular        Plasma membrane   Glycoprotein   EC marker
      Intercellular adhesion molecule 2                                                              ICAM2_HUMAN   [P13598](P13598)           ICAM2                            Plasma membrane   Glycoprotein   EC marker
      Integrin alpha-2                                                                               ITA2_HUMAN    [P17301](P17301)           ITGA2                            Plasma membrane   Glycoprotein   
      Integrin alpha-5                                                                               ITA5_HUMAN    [P08648](P08648)           ITGA5                            Plasma membrane   Glycoprotein   
      Integrin alpha-6                                                                               ITA6_HUMAN    [P23229](P23229)           ITGA6                            Plasma membrane   Glycoprotein   
      Integrin beta-1                                                                                ITB1_HUMAN    [P05556](P05556)           ITGB1                            Plasma membrane   Glycoprotein   EC marker
      Protein jagged-1                                                                               JAG1_HUMAN    [P78504](P78504)           JAG1                             Plasma membrane   Glycoprotein   
      Protein jagged-2                                                                               JAG2_HUMAN    [Q9Y219](Q9Y219)           JAG2                             Plasma membrane   Glycoprotein   
      Junctional adhesion molecule A                                                                 JAM1_HUMAN    [Q9Y624](Q9Y624)           F11R                             Plasma membrane   Glycoprotein   
      BTB/POZ domain-containing protein KCTD12                                                       KCD12_HUMAN   [Q96CX2](Q96CX2)           KCTD12                           Plasma membrane                  
      Kinectin                                                                                       KTN1_HUMAN    [Q86UP2](Q86UP2)           KTN1                             Plasma membrane   Glycoprotein   
      Lysosome-associated membrane glycoprotein 1                                                    LAMP1_HUMAN   [P11279](P11279)           LAMP1                            Plasma membrane   Glycoprotein   
      Low-density lipoprotein receptor                                                               LDLR_HUMAN    [P01130](P01130)           LDLR                             Plasma membrane   Glycoprotein   
      Low-density lipoprotein receptor-related protein 5                                             LRP5_HUMAN    [O75197](O75197)           LRP5                             Plasma membrane   Glycoprotein   
      Lymphatic vessel endothelial hyaluronic acid receptor 1                                        LYVE1_HUMAN   [Q9Y5Y7](Q9Y5Y7)           LYVE1                            Plasma membrane   Glycoprotein   EC marker
      Hepatocyte growth factor receptor                                                              MET_HUMAN     [P08581](P08581)           MET         Extracellular        Plasma membrane   Glycoprotein   
      Cation-independent mannose-6-phosphate receptor                                                MPRI_HUMAN    [P11717](P11717)           IGF2R                            Plasma membrane   Glycoprotein   
      C-type mannose receptor 2                                                                      MRC2_HUMAN    [Q9UBG0](Q9UBG0)           MRC2                             Plasma membrane   Glycoprotein   
      Cell surface glycoprotein MUC18                                                                MUC18_HUMAN   [P43121](P43121)           MCAM                             Plasma membrane   Glycoprotein   EC marker
      Neuroligin-1                                                                                   NLGN1_HUMAN   [Q8N2Q7](Q8N2Q7)           NLGN1                            Plasma membrane   Glycoprotein   
      Neuronal cell adhesion molecule                                                                NRCAM_HUMAN   [Q92823](Q92823)           NRCAM                            Plasma membrane   Glycoprotein   
      Neuropilin-1                                                                                   NRP1_HUMAN    [O14786](O14786)           NRP1        Extracellular        Plasma membrane   Glycoprotein   
      Neuropilin-2                                                                                   NRP2_HUMAN    [O60462](O60462)           NRP2                             Plasma membrane   Glycoprotein   
      Neurotrimin                                                                                    NTRI_HUMAN    [Q9P121](Q9P121)           NTM                              Plasma membrane   Glycoprotein   
      Protocadherin-10                                                                               PCD10_HUMAN   [Q9P2E7](Q9P2E7)           PCDH10                           Plasma membrane   Glycoprotein   
      Protocadherin-12                                                                               PCD12_HUMAN   [Q9NPG4](Q9NPG4)           PCDH12                           Plasma membrane   Glycoprotein   
      Protocadherin gamma-A11                                                                        PCDGB_HUMAN   [Q9Y5H2](Q9Y5H2)           PCDHGA11                         Plasma membrane   Glycoprotein   
      Protocadherin gamma-A12                                                                        PCDGC_HUMAN   [O60330](O60330)           PCDHGA12                         Plasma membrane   Glycoprotein   
      Protocadherin gamma-B7                                                                         PCDGJ_HUMAN   [Q9Y5F8](Q9Y5F8)           PCDHGB7                          Plasma membrane   Glycoprotein   
      Protocadherin-1                                                                                PCDH1_HUMAN   [Q08174](Q08174)           PCDH1                            Plasma membrane   Glycoprotein   
      Protocadherin-9                                                                                PCDH9_HUMAN   [Q9HC56](Q9HC56)           PCDH9                            Plasma membrane   Glycoprotein   
      Programmed cell death 1 ligand 2                                                               PD1L2_HUMAN   [Q9BQ51](Q9BQ51)           PDCD1LG2    Extracellular        Plasma membrane   Glycoprotein   
      Platelet endothelial cell adhesion molecule                                                    PECA1_HUMAN   [P16284](P16284)           PECAM1                           Plasma membrane   Glycoprotein   EC marker
      Plexin-D1                                                                                      PLXD1_HUMAN   [Q9Y4D7](Q9Y4D7)           PLXND1                           Plasma membrane   Glycoprotein   
      Inactive tyrosine-protein kinase 7                                                             PTK7_HUMAN    [Q13308](Q13308)           PTK7                             Plasma membrane   Glycoprotein   
      Receptor-type tyrosine-protein phosphatase delta                                               PTPRD_HUMAN   [P23468](P23468)           PTPRD                            Plasma membrane   Glycoprotein   
      Receptor-type tyrosine-protein phosphatase F                                                   PTPRF_HUMAN   [P10586](P10586)           PTPRF                            Plasma membrane   Glycoprotein   
      Receptor-type tyrosine-protein phosphatase kappa                                               PTPRK_HUMAN   [Q15262](Q15262)           PTPRK                            Plasma membrane   Glycoprotein   
      Poliovirus receptor                                                                            PVR_HUMAN     [P15151](P15151)           PVR         Extracellular        Plasma membrane   Glycoprotein   
      Poliovirus receptor-related protein 2                                                          PVRL2_HUMAN   [Q92692](Q92692)           PVRL2                            Plasma membrane   Glycoprotein   EC marker
      Roundabout homolog 1                                                                           ROBO1_HUMAN   [Q9Y6N7](Q9Y6N7)           ROBO1                            Plasma membrane   Glycoprotein   
      Roundabout homolog 4                                                                           ROBO4_HUMAN   [Q8WZ75](Q8WZ75)           ROBO4                            Plasma membrane   Glycoprotein   
      Syndecan-4                                                                                     SDC4_HUMAN    [P31431](P31431)           SDC4        Extracellular        Plasma membrane   Glycoprotein   
      Semaphorin-4D                                                                                  SEM4D_HUMAN   [Q92854](Q92854)           SEMA4D                           Plasma membrane   Glycoprotein   
      Semaphorin-6B                                                                                  SEM6B_HUMAN   [Q9H3T3](Q9H3T3)           SEMA6B                           Plasma membrane   Glycoprotein   
      Tyrosine-protein phosphatase non-receptor type substrate 1                                     SHPS1_HUMAN   [P78324](P78324)           SIRPA                            Plasma membrane   Glycoprotein   
      Stabilin-1                                                                                     STAB1_HUMAN   [Q9NY15](Q9NY15)           STAB1                            Plasma membrane   Glycoprotein   EC marker
      Transferrin receptor protein 1                                                                 TFR1_HUMAN    [P02786](P02786)           TFRC        Extracellular        Plasma membrane   Glycoprotein   
      Tyrosine-protein kinase receptor Tie-1                                                         TIE1_HUMAN    [P35590](P35590)           TIE1                             Plasma membrane   Glycoprotein   
      Tyrosine-protein kinase receptor UFO                                                           UFO_HUMAN     [P30530](P30530)           AXL         Extracellular        Plasma membrane   Glycoprotein   
      Vascular endothelial growth factor receptor 2                                                  VGFR2_HUMAN   [P35968](P35968)           KDR         Extracellular        Plasma membrane   Glycoprotein   EC marker
      Vascular endothelial growth factor receptor 3                                                  VGFR3_HUMAN   [P35916](P35916)           FLT4        Extracellular        Plasma membrane   Glycoprotein   EC marker
      Very low-density lipoprotein receptor                                                          VLDLR_HUMAN   [P98155](P98155)           VLDLR                            Plasma membrane   Glycoprotein   
  Miscellaneous membrane proteins                                                                                                                                                                               
      Brain acid soluble protein 1                                                                   BASP1_HUMAN   [P80723](P80723)           BASP1                            Plasma membrane                  
      DnaJ homolog subfamily B member 4                                                              DNJB4_HUMAN   [Q9UDY4](Q9UDY4)           DNAJB4                           Plasma membrane                  
      RNA-binding protein EWS                                                                        EWS_HUMAN     [Q01844](Q01844)           EWSR1                            Plasma membrane                  
      Nck-associated protein 1                                                                       NCKP1_HUMAN   [Q9Y2A7](Q9Y2A7)           NCKAP1                           Plasma membrane                  
      Na(+)/H(+) exchange regulatory cofactor NHE-RF2                                                NHRF2_HUMAN   [Q15599](Q15599)           SLC9A3R2                         Plasma membrane                  
      Polymerase I and transcript release factor                                                     PTRF_HUMAN    [Q6NZI2](Q6NZI2)           PTRF                             Plasma membrane                  
      Serum deprivation-response protein                                                             SDPR_HUMAN    [O95810](O95810)           SDPR                             Plasma membrane                  
      Sushi repeat-containing protein SRPX2                                                          SRPX2_HUMAN   [O60687](O60687)           SRPX2       Extracellular                                         
      Erythrocyte band 7 integral membrane protein                                                   STOM_HUMAN    [P27105](P27105)           STOM                             Plasma membrane                  
  Miscellaneous secreted proteins                                                                                                                                                                               
      Peptidyl-glycine alpha-amidating monooxygenase                                                 AMD_HUMAN     [P19021](P19021)           PAM         Extracellular                          Glycoprotein   
      Angiopoietin-2                                                                                 ANGP2_HUMAN   [O15123](O15123)           ANGPT2      Extracellular                          Glycoprotein   
      Endothelin-1                                                                                   EDN1_HUMAN    [P05305](P05305)           EDN1        Extracellular                                         
      Endothelial cell-specific molecule 1                                                           ESM1_HUMAN    [Q9NQ30](Q9NQ30)           ESM1        Extracellular                          Glycoprotein   
      Protein FAM3C                                                                                  FAM3C_HUMAN   [Q92520](Q92520)           WNT16       Extracellular                                         
      Epididymal secretory protein E1                                                                NPC2_HUMAN    [P61916](P61916)           NPC2        Extracellular                          Glycoprotein   
      Programmed cell death protein 10                                                               PDC10_HUMAN   [Q9BUL8](Q9BUL8)           PDCD10                           Plasma membrane                  
      Prolactin-inducible protein                                                                    PIP_HUMAN     [P12273](P12273)           PIP         Extracellular                          Glycoprotein   
      Sulfhydryl oxidase 1                                                                           QSOX1_HUMAN   [O00391](O00391)           QSOX1       Extracellular                          Glycoprotein   
      Secretoglobin family 1D member 2                                                               SG1D2_HUMAN   [O95969](O95969)           SCGB1D2     Extracellular                                         
      Thioredoxin[*^a^*](#TFI-1){ref-type="table-fn"}                                                THIO_HUMAN    [P10599](P10599)           TXN         Extracellular                                         
      Thymosin beta-4                                                                                TYB4_HUMAN    [P62328](P62328)           TMSB4X      Extracellular                                         
  Protease inhibitors                                                                                                                                                                                           
      Cystatin-C                                                                                     CYTC_HUMAN    [P01034](P01034)           CST3        Extracellular                          Glycoprotein   
      Leukocyte elastase inhibitor                                                                   ILEU_HUMAN    [P30740](P30740)           SERPINB1    Extracellular                                         
      Inter-alpha-trypsin inhibitor heavy chain H2                                                   ITIH2_HUMAN   [P19823](P19823)           ITIH2       Extracellular                          Glycoprotein   
      Serpin B9                                                                                      SPB9_HUMAN    [P50453](P50453)           SERPINB9    Extracellular                                         
      Metalloproteinase inhibitor 1                                                                  TIMP1_HUMAN   [P01033](P01033)           TIMP1       Extracellular                          Glycoprotein   
      Metalloproteinase inhibitor 2                                                                  TIMP2_HUMAN   [P16035](P16035)           TIMP2       Extracellular                                         
  Proteases                                                                                                                                                                                                     
      Angiotensin-converting enzyme                                                                  ACE_HUMAN     [P12821](P12821)           ACE         Extracellular        Plasma membrane   Glycoprotein   EC marker
      Disintegrin and metalloproteinase domain-containing protein 10                                 ADA10_HUMAN   [O14672](O14672)           ADAM10                           Plasma membrane   Glycoprotein   
      Aminopeptidase B                                                                               AMPB_HUMAN    [Q9H4A4](Q9H4A4)           RNPEP       Extracellular                                         
      Aminopeptidase N                                                                               AMPN_HUMAN    [P15144](P15144)           ANPEP                            Plasma membrane   Glycoprotein   
      Bone morphogenetic protein 1                                                                   BMP1_HUMAN    [P13497](P13497)           BMP1        Extracellular                          Glycoprotein   
      Cathepsin B                                                                                    CATB_HUMAN    [P07858](P07858)           CTSB        Extracellular                          Glycoprotein   
      Cathepsin D                                                                                    CATD_HUMAN    [P07339](P07339)           CTSD        Extracellular                          Glycoprotein   
      Cathepsin Z                                                                                    CATZ_HUMAN    [Q9UBR2](Q9UBR2)           CTSZ        Extracellular                          Glycoprotein   
      Carboxypeptidase Q                                                                             CBPQ_HUMAN    [Q9Y646](Q9Y646)           CPQ         Extracellular                          Glycoprotein   
      Dipeptidyl peptidase 2                                                                         DPP2_HUMAN    [Q9UHL4](Q9UHL4)           DPP7        Extracellular                          Glycoprotein   
      Dipeptidyl peptidase 3                                                                         DPP3_HUMAN    [Q9NY33](Q9NY33)           DPP3                             Plasma membrane                  
      Endoplasmic reticulum aminopeptidase 1                                                         ERAP1_HUMAN   [Q9NZ08](Q9NZ08)           ERAP1       Extracellular                          Glycoprotein   
      Furin                                                                                          FURIN_HUMAN   [P09958](P09958)           FURIN                            Plasma membrane   Glycoprotein   
      Gamma-glutamyl hydrolase                                                                       GGH_HUMAN     [Q92820](Q92820)           GGH         Extracellular                          Glycoprotein   
      Serine protease HTRA1                                                                          HTRA1_HUMAN   [Q92743](Q92743)           HTRA1       Extracellular                                         
      Insulin-degrading enzyme                                                                       IDE_HUMAN     [P14735](P14735)           IDE         Extracellular        Plasma membrane                  
      Interstitial collagenase                                                                       MMP1_HUMAN    [P03956](P03956)           MMP1        Extracellular                          Glycoprotein   
      Stromelysin-2                                                                                  MMP10_HUMAN   [P09238](P09238)           MMP10       Extracellular                                         
      Matrix metalloproteinase-14                                                                    MMP14_HUMAN   [P50281](P50281)           MMP14                            Plasma membrane                  
      72 kDa type IV collagenase                                                                     MMP2_HUMAN    [P08253](P08253)           MMP2        Extracellular                          Glycoprotein   
      Lysosomal Pro-X carboxypeptidase                                                               PCP_HUMAN     [P42785](P42785)           PRCP                             Plasma membrane   Glycoprotein   
      Serine protease 23                                                                             PRS23_HUMAN   [O95084](O95084)           PRSS23      Extracellular                          Glycoprotein   
      Ubiquitin carboxyl-terminal hydrolase 14                                                       UBP14_HUMAN   [P54578](P54578)           USP14                            Plasma membrane                  
  Signal transduction proteins                                                                                                                                                                                  
      Adenylyl cyclase-associated protein 1                                                          CAP1_HUMAN    [Q01518](Q01518)           CAP1                             Plasma membrane                  
      Cell division control protein 42 homolog                                                       CDC42_HUMAN   [P60953](P60953)           CDC42                            Plasma membrane                  
      Contactin-associated protein-like 3                                                            CNTP3_HUMAN   [Q9BZ76](Q9BZ76)           CNTNAP3     Extracellular        Plasma membrane   Glycoprotein   
      Adapter molecule crk                                                                           CRK_HUMAN     [P46108](P46108)           CRK                              Plasma membrane                  
      Ras GTPase-activating protein-binding protein 1                                                G3BP1_HUMAN   [Q13283](Q13283)           G3BP1                            Plasma membrane                  
      Growth arrest-specific protein 6                                                               GAS6_HUMAN    [Q14393](Q14393)           GAS6        Extracellular                          Glycoprotein   
      Interferon-induced guanylate-binding protein 1                                                 GBP1_HUMAN    [P32455](P32455)           GBP1        Extracellular                                         
      Guanine nucleotide-binding protein G(i) subunit alpha-2                                        GNAI2_HUMAN   [P04899](P04899)           GNAI2                            Plasma membrane                  
      Glypican-1                                                                                     GPC1_HUMAN    [P35052](P35052)           GPC1        Extracellular        Plasma membrane   Glycoprotein   
      Hedgehog-interacting protein                                                                   HHIP_HUMAN    [Q96QV1](Q96QV1)           HHIP        Extracellular        Plasma membrane   Glycoprotein   
      Histidine triad nucleotide-binding protein 1[*^a^*](#TFI-1){ref-type="table-fn"}               HINT1_HUMAN   [P49773](P49773)           HINT1                            Plasma membrane                  
      Integrin-linked protein kinase                                                                 ILK_HUMAN     [Q13418](Q13418)           ILK                              Plasma membrane                  
      Ras GTPase-activating-like protein IQGAP1                                                      IQGA1_HUMAN   [P46940](P46940)           IQGAP1                           Plasma membrane                  
      cAMP-dependent protein kinase type II-alpha regulatory subunit                                 KAP2_HUMAN    [P13861](P13861)           PRKAR2A                          Plasma membrane                  
      Ras-related protein Rab-18                                                                     RAB18_HUMAN   [Q9NP72](Q9NP72)           RAB18                            Plasma membrane                  
      Ras-related protein Rab-5C                                                                     RAB5C_HUMAN   [P51148](P51148)           RAB5C                            Plasma membrane                  
      Ras-related C3 botulinum toxin substrate 1                                                     RAC1_HUMAN    [P63000](P63000)           RAC1                             Plasma membrane                  
      Ras-related protein Ral-A                                                                      RALA_HUMAN    [P11233](P11233)           RALA                             Plasma membrane                  
      Ras-related protein Rap-1b                                                                     RAP1B_HUMAN   [P61224](P61224)           RAP1B                            Plasma membrane                  
      GTPase NRas                                                                                    RASN_HUMAN    [P01111](P01111)           NRAS                             Plasma membrane                  
      Ras-related protein Rab-11A                                                                    RB11A_HUMAN   [P62491](P62491)           RAB11A                           Plasma membrane                  
      Rho-related GTP-binding protein RhoC                                                           RHOC_HUMAN    [P08134](P08134)           RHOC                             Plasma membrane                  
      Rho-associated protein kinase 2                                                                ROCK2_HUMAN   [O75116](O75116)           ROCK2                            Plasma membrane                  
      Ras-related protein R-Ras2                                                                     RRAS2_HUMAN   [P62070](P62070)           RRAS2                            Plasma membrane                  
      Protein S100-A6[*^a^*](#TFI-1){ref-type="table-fn"}                                            S10A6_HUMAN   [P06703](P06703)           S100A6                           Plasma membrane                  
      Protein S100-A10[*^a^*](#TFI-1){ref-type="table-fn"}                                           S10AA_HUMAN   [P60903](P60903)           S100A10                          Plasma membrane                  
      Switch-associated protein 70                                                                   SWP70_HUMAN   [Q9UH65](Q9UH65)           SWAP70                           Plasma membrane                  
      NEDD8-activating enzyme E1 regulatory subunit                                                  ULA1_HUMAN    [Q13564](Q13564)           NAE1                             Plasma membrane                  
  Transport-related proteins                                                                                                                                                                                    
      AP-2 complex subunit alpha-1                                                                   AP2A1_HUMAN   [O95782](O95782)           AP2A1                            Plasma membrane                  
      AP-2 complex subunit alpha-2                                                                   AP2A2_HUMAN   [O94973](O94973)           AP2A2                            Plasma membrane                  
      ADP-ribosylation factor 1                                                                      ARF1_HUMAN    [P84077](P84077)           ARF1                             Plasma membrane                  
      ADP-ribosylation factor 6                                                                      ARF6_HUMAN    [P62330](P62330)           ARF6                             Plasma membrane                  
      ADP-ribosylation factor-like protein 3                                                         ARL3_HUMAN    [P36405](P36405)           ARL3                             Plasma membrane                  
      Beta-arrestin-1                                                                                ARRB1_HUMAN   [P49407](P49407)           ARRB1                            Plasma membrane                  
      Chloride intracellular channel protein 1                                                       CLIC1_HUMAN   [O00299](O00299)           CLIC1                            Plasma membrane                  
      Chloride intracellular channel protein 4                                                       CLIC4_HUMAN   [Q9Y696](Q9Y696)           CLIC4                            Plasma membrane                  
      Clusterin                                                                                      CLUS_HUMAN    [P10909](P10909)           CLU         Extracellular                          Glycoprotein   
      Coatomer subunit beta                                                                          COPB_HUMAN    [P53618](P53618)           COPB1                            Plasma membrane                  
      EH domain-containing protein 1                                                                 EHD1_HUMAN    [Q9H4M9](Q9H4M9)           EHD1                             Plasma membrane                  
      EH domain-containing protein 2                                                                 EHD2_HUMAN    [Q9NZN4](Q9NZN4)           EHD2                             Plasma membrane                  
      Palmitoyl-protein thioesterase 1                                                               PPT1_HUMAN    [P50897](P50897)           PPT1        Extracellular                          Glycoprotein   
      Protein S100-A13                                                                               S10AD_HUMAN   [Q99584](Q99584)           S100A13     Extracellular                                         
      Solute carrier family 12 member 2                                                              S12A2_HUMAN   [P55011](P55011)           SLC12A2                          Plasma membrane                  
      Proactivator polypeptide                                                                       SAP_HUMAN     [P07602](P07602)           PSAP        Extracellular                          Glycoprotein   
      Syntaxin-binding protein 1                                                                     STXB1_HUMAN   [P61764](P61764)           STXBP1                           Plasma membrane                  
      Syntaxin-binding protein 3                                                                     STXB3_HUMAN   [O00186](O00186)           STXBP3                           Plasma membrane                  
      Transmembrane emp24 domain-containing protein 10                                               TMEDA_HUMAN   [P49755](P49755)           TMED10                           Plasma membrane   Glycoprotein   
      Vesicle-associated membrane protein-associated protein A                                       VAPA_HUMAN    [Q9P0L0](Q9P0L0)           VAPA                             Plasma membrane                  

^*a*^ These proteins were also identified in the cellular proteome according to the difference gel electrophoresis analysis presented in the supplemental data.

Immunoblots confirmed that proteins such as fibronectin and biglycan were constitutively secreted ([Fig. 1](#F1){ref-type="fig"}*B*). Others such as agrin and lymphatic vessel endothelial hyaluronic acid receptor 1 were released upon PMA stimulation, providing an explanation for why previously unidentified proteins ([@B8], [@B10]) were found in the present analysis ([Fig. 1](#F1){ref-type="fig"}*C*). An overlay between secreted (Cy3 and Cy 5; green and red color) and cellular (Cy 2; blue color) proteins is shown in [Fig. 1](#F1){ref-type="fig"}*D*. Common spots were numbered ([supplemental Fig. S2](http://www.mcponline.org/cgi/content/full/M112.024018/DC1)) and identified via LC-MS/MS ([supplemental Table S3](http://www.mcponline.org/cgi/content/full/M112.024018/DC1)). Certain proteins, such as von Willebrand antigen 2 (a propeptide of vWF, AA 23--763), were clearly more abundant in the secretome of PMA-treated HUVECs.

#### The Endothelial Glycoproteome

Among the 1252 identified proteins were 253 extracellular or plasma membrane proteins (approximately 20%) related to cell adhesion, blood coagulation, hemostasis, signaling transduction, and protein transportation, of which 166 were known glycoproteins ([Table I](#TI){ref-type="table"}). To further characterize this subproteome, we employed a glycoproteomics approach. Secreted proteins were precipitated and digested with trypsin, and tryptic peptides were labeled with TMT^0^ to increase their charge state prior to enrichment by means of zwitterionic hydrophilic interaction liquid chromatography purification ([@B24]). For glycosite identification, an indirect and a direct strategy were pursued ([Fig. 2](#F2){ref-type="fig"}*A*): (i) digestion with PNGase F in the presence of ^18^O water to label the conversion of asparagine to aspartic acid upon the removal of N-glycans, and (ii) alternating HCD and ETD (HCD-alt-ETD) or HCD-product-dependent ETD (HCD-pd-ETD) fragmentation on an Orbitrap Elite MS ([@B24]).

![**Glycoproteomics.** *A*, glycopeptide identification workflow. Comparison of direct and indirect glycopeptide detection using HCD-ETD and ^18^O-deamidation after PNGase F + H~2~^18^O treatment, respectively: identified unique glycopeptides (*B*), unique glycosylation sites (*C*), and unique glycoproteins (*D*).](zjw0041344130002){#F2}

There was little overlap in the numbers of glycopeptides ([Fig. 2](#F2){ref-type="fig"}*B*) and glycosylation sites ([Fig. 2](#F2){ref-type="fig"}*C*) identified via the direct (HCD-ETD) and the indirect (PNGase F + H~2~^18^O) methods. Better agreement was observed at the protein level ([Fig. 2](#F2){ref-type="fig"}*D*). With the indirect (PNGase F + H~2~^18^O) method, 27 peptides were identified with N\[+2.99\] modification at non-consensus sequence, out of 1139 total identified peptides with N\[+2.99\]. This anomaly rate of 2.4% (27/1139) combines the rate of false identifications and the rate of chance deamidations in ^18^O water that were not in the consensus sequence of glycosylation (*i.e.* N-X(not P)-S/T). All glycopeptides identified are listed in [Table II](#TII){ref-type="table"} and [supplemental Table S4](http://www.mcponline.org/cgi/content/full/M112.024018/DC1). Three spectra (full MS, HCD, and ETD) from a neuronal cell adhesion molecule (UniProt accession number Q92823) (AA - ~222~FNHTQTIQQK~231~) are presented in [Fig. 3](#F3){ref-type="fig"}.

###### Glycopeptides identified via the HCD-ETD method

  Protein name                                                 UniProt ID                                                                 Peptide                                                               Glycosite   Type                Glycans                        Observed *m*/*z*   Z      ΔMass (ppm)
  ------------------------------------------------------------ -------------------------------------------------------------------------- --------------------------------------------------------------------- ----------- ------------------- ------------------------------ ------------------ ------ -------------
  Afamin                                                       AFAM_HUMAN                                                                 \$DIENFN(+1702.582)\^STQk                                             N33         Known               Hex8HexNAc2                    843.359            4      −5.8
  Aminopeptidase N                                             AMPN_HUMAN                                                                 \$kLN(+892.318)YTLSQGHRVVLR                                           N128        Known               Hex3HexNAc2                    781.916            4      −2.8
                                                                                                                                          \$NAN(+2042.720)\^SSPVAsTTPSASATTNPASATTLDQSk                         N42         Novel               Hex4HexNAc4NeuAc2              1095.276           5      −0.3
  Alpha-N-acetylglucosaminidase                                ANAG_HUMAN                                                                 \$SVYN(+1257.450)cSGEAcRGhNRSPLVR                                     N503        Potential           Hex4HexNAc3                    954.927            4      1.1
  Angiopoietin-2                                               ANGP2_HUMAN                                                                \$kIVTATVN(+568.212)NSVLQk                                            N240        Potential           Hex1HexNAc2                    689.645            4      −0.3
                                                                                                                                          \$SGhTTNGIYTLTFPN(+1038.375)STEEIk                                    N304        Potential           Hex3HexNAc2dHex1               763.565            5      −1.4
  Attractin                                                    ATRN_HUMAN                                                                 \$DLDMFIN(+1241.455)ASk                                               N1198       Known               Hex3HexNAc3dHex1               948.450            3      6.7
                                                                                                                                          \$GcScFSDWQGPGcSVPVPAN(+1095.397)QSFWTR                               N325        Potential           Hex3HexNAc3                    1077.708           4      −2.1
                                                                                                                                          \$GcScFSDWQGPGcSVPVPAN(+892.317)QSFWTREEYSnLk                         N325        Potential           Hex3HexNAc2                    1040.061           5      −2.4
  Cadherin-2                                                   CADH2_HUMAN                                                                \$EQIARFHLRAHAVDInGNQVENPIDIVINVIDMNDNRPEFLHQVWN(+1751.624)GTVPEGSk   N273        Known               Hex4HexNAc4NeuAc1              930.011            9      2.8
  Cadherin-5                                                   CADH5_HUMAN                                                                \$EN(+1054.370)\^ISEYHLTAVIVDk                                        N112        Known               Hex4HexNAc2                    815.146            4      0.7
                                                                                                                                          \$ELDREVYPWYN(+1241.455)LTVEAk                                        N442        Known               Hex3HexNAc3dHex1               954.972            4      10.0
  CD109 antigen                                                CD109_HUMAN                                                                \$LNLYLDSVN(+1038.375)\^ETQFcVNIPAVR                                  N1355       Novel               Hex3HexNAc2dHex1               938.447            4      1.5
                                                                                                                                          \$kkN(+1540.529)ITk                                                   N279        Potential           Hex7HexNAc2                    793.410            4      −0.9
                                                                                                                                          \$QN(+1848.640)\^STMFSLTPENSWTPk                                      N513        Novel               Hex8HexNAc2dHex1               1072.719           4      1.0
  CD59 glycoprotein                                            CD59_HUMAN                                                                 [\$TAVN(+1954.704)\^csSDFDAcLITk]{.ul}                                N43         Known               Hex4HexNAc5NeuAc1              1077.708           4      9.1
  Complement factor I                                          CFAI_HUMAN                                                                 \$FLNN(+1054.370)GTcTAEGk                                             N103        Known               Hex4HexNAc2                    939.094            3      −4.0
                                                                                                                                          \$LISN(+3534.244)\^cSk                                                N494        Potential           Hex8HexNAc6dHex1NeuAc3         1207.501           4      5.7
  CAP-Gly domain-containing linker protein 1                   CLIP1_HUMAN                                                                \$GEN(+1257.450)\^ASAk                                                N1263       Novel               Hex4HexNAc3                    802.359            3      −1.4
                                                                                                                                          \$GEN(+1784.635)ASAk                                                  N1263       Novel               Hex6HexNAc4                    970.437            3      10.7
                                                                                                                                          \$EPSATPPISN(+2188.741)LTk                                            N187        Novel               Hex11HexNAc2                   999.192            4      −6.9
                                                                                                                                          \$ANEN(+1200.428)\^ASFLQkSIEDMTVk                                     N971        Novel               Hex4HexNAc2dHex1               980.724            4      2.6
                                                                                                                                          \$ANEN(+1216.423)\^ASFLQkSIEDMTVk                                     N971        Novel               Hex5HexNAc2                    985.232            4      11.0
                                                                                                                                          \$ANEN(+1257.449)ASFLQkSIEDMTVk                                       N971        Novel               Hex4HexNAc3                    989.489            4      8.2
                                                                                                                                          \$ANEN(+1444.534)ASFLQkSIEDMTVk                                       N971        Novel               Hex3HexNAc4dHex1               1036.764           4      9.3
  Ephrin type-A receptor 2                                     EPHA2_HUMAN                                                                \$TASVSIN(+892.317)QTEPPkVRLEGR                                       N435        Known               Hex3HexNAc2                    856.694            4      −0.4
  Fibrous sheath-interacting protein 2                         FSIP2_HUMAN                                                                \$IGWEYESTN(+1751.624)ISR                                             N1423       Novel               Hex4HexNAc4NeuAc1              858.373            4      0.8
                                                                                                                                          \$TITFSAN(+1362.481)VSSHEhTYk                                         N1675       Novel               Hex5HexNAc2dHex1               912.923            4      3.0
                                                                                                                                          \$GGIN(+892.318)ISGQGSIISAQVSPTR                                      N215        Novel               Hex3HexNAc2                    1020.509           3      1.5
                                                                                                                                          \$ENSN(+1200.428)FSQLALSNEILLGHkEk                                    N2216       Novel               Hex4HexNAc2dHex1               708.363            6      6.3
                                                                                                                                          \$mPIEN(+1444.534)LSSIQQk                                             N2824       Novel               Hex3HexNAc4dHex1               825.398            4      0.8
                                                                                                                                          \$YN(+2204.772)k                                                      N427        Novel               Hex5HexNAc4NeuAc2              1026.779           3      7.7
  N-acetylglucosamine-6-sulfatase                              GNS_HUMAN                                                                  \$LVkRLEFTGELN(+2018.708)\^NTYIFYTSDnGYHTGQFSLPIDkR                   N317        Known               Hex6HexNAc3dHex1NeuAc1         696.027            10     −9.6
                                                                                                                                          \$GPGIkPN(+1540.529)QTSk                                              N362        Potential           Hex7HexNAc2                    835.657            4      −0.8
  Golgin subfamily A member 4                                  GOGA4_HUMAN                                                                \$ELEhVN(+1735.630)\^LSVk                                             N1612       Novel               Hex3HexNAc4dHex1NeuAc1         848.139            4      −3.9
                                                                                                                                          \$kELEHVN(+1038.375)LSVk                                              N1612       Novel               Hex3HexNAc2dHex1               752.648            4      0.8
                                                                                                                                          \$kELEHVN(+1524.534)LSVk                                              N1612       Novel               Hex6HexNAc2dHex1               874.186            4      −1.6
                                                                                                                                          \$SLQENkN(+1257.450)QSk                                               N585        Novel               Hex4HexNAc3                    777.391            4      10.2
                                                                                                                                          \$TRILELESSLEkSLQENkN(+1216.423)QSk                                   N585        Novel               Hex5HexNAc2                    938.686            5      −2.3
  Intercellular adhesion molecule 2                            ICAM2_HUMAN                                                                [\$GSLEVN(+2028.741)\^cSTTcNQPEVGGLETSLDk]{.ul}                       N47         Known               Hex5HexNAc6                    1039.861           5      5.1
                                                                                                                                          \$HYLVSN(+568.212)ISHDTVLQcHFTcSGk                                    N82         Known               Hex1HexNAc2                    905.687            4      −0.6
  ICOS ligand                                                  ICOSL_HUMAN                                                                \$IARTPSVNIGccIENVLLQQN(+2457.877)LTVGSQTGNDIGER                      N225        Potential           Hex8HexNAc5dHex1               724.219            9      −5.4
                                                                                                                                          \$IARTPSVNIGccIENVLLQQN(+2594.937)\^LTVGSQTGNDIGER                    N225        Potential           Hex4HexNAc6dHex1NeuAc2         667.906            10     0.1
  Interleukin-6 receptor subunit beta                          IL6RB_HUMAN                                                                \$SHLQN(+568.212)YTVNATkLTVNLTNDRYLATLTVRNLVGk                        N379        Known               Hex1HexNAc2                    725.691            7      6.5
                                                                                                                                          \$SHLQN(+568.212)YTVNATkLTVNLTNDRYLATLTVRNLVGk                        N379        Known               Hex1HexNAc2                    1015.568           5      9.4
                                                                                                                                          \$LTVN(+1460.529)LTNDRYLATLTVRNLVGk                                   N390        Known               Hex4HexNAc4                    877.848            5      −8.4
                                                                                                                                          \$QN(+568.212)cSQHESSPDIsHFER                                         N818        Novel               Hex1HexNAc2                    733.814            4      8.8
  Integrin alpha-3                                             ITA3_HUMAN                                                                 \$DVRkLLLSIN(+892.317)VTNTR                                           N656        Potential           Hex3HexNAc2                    1028.554           3      −2.2
                                                                                                                                          \$AHcVWLEcPIPDAPVVTN(+1362.481)VTVk                                   N926        Potential           Hex5HexNAc2dHex1               864.223            5      8.3
  Integrin beta-1                                              ITB1_HUMAN                                                                 \$kNkNVTN(+1444.534)\^RSk                                             N97         Potential           Hex3HexNAc4dHex1               888.710            4      2.8
  Junctional adhesion molecule C                               JAM3_HUMAN                                                                 \$IWN(+1581.555)VTRRDSALYRcEVVARNDR                                   N104        Potential           Hex6HexNAc3                    1139.528           4      −4.8
                                                                                                                                          \$IWN(+892.318)\^VTR                                                  N104        Potential           Hex3HexNAc2                    643.303            3      −0.7
  Lysosome-associated membrane glycoprotein 1                  LAMP1_HUMAN                                                                [\$GHTLTLN(+1378.476)FTR]{.ul}                                        N103        Known               Hex6HexNAc2                    921.421            3      −0.4
                                                               [\$GHTLTLN(+1540.529)FTR]{.ul}                                             N103                                                                  Known       Hex7HexNAc2         975.439                        3                  −0.4   
                                                                                                                                          \$YNVSGTNGTcLLASMGLQLN(+2042.720)\^LTYERkDNTTVTRLLnINPNk              N241        Known               Hex4HexNAc4NeuAc2              734.661            10     6.4
                                                                                                                                          \$kDN(+2059.735)TTVTR                                                 N249        Known               Hex5HexNAc4dHex1NeuAc1         861.641            4      1.0
                                                                                                                                          \$kDN(+2204.772)TTVTR                                                 N249        Known               Hex5HexNAc4NeuAc2              898.156            4      5.8
                                                                                                                                          \$kDN(+2350.830)TTVTR                                                 N249        Known               Hex5HexNAc4dHex1NeuAc2         934.414            4      −0.2
                                                                                                                                          \$kDN(+2569.905)TTVTR                                                 N249        Known               Hex6HexNAc5NeuAc2              989.440            4      6.2
                                                                                                                                          \$kDN(+2570.925)TTVTR                                                 N249        Known               Hex6HexNAc5dHex2NeuAc1         989.690            4      1.0
                                                                                                                                          \$kDN(+2571.946)TTVTR                                                 N249        Known               Hex6HexNAc5dHex4               989.690            4      −2.4
                                                                                                                                          \$kDN(+2715.963)\^TTVTR                                               N249        Known               Hex6HexNAc5dHex1NeuAc2         1031.190           4      −2.0
                                                                                                                                          \$kDN(+2715.963)TTVTR                                                 N249        Known               Hex6HexNAc5dHex1NeuAc2         1025.696           4      −0.9
                                                                                                                                          \$kDN(+2717.978)TTVTR                                                 N249        Known               Hex8HexNAc7                    1025.949           4      −1.2
                                                                                                                                          \$kDN(+2861.000)TTVTR                                                 N249        Known               Hex6HexNAc5NeuAc3              1062.211           4      3.1
                                                                                                                                          \$kDN(+2864.036)TTVTR                                                 N249        Known               Hex8HexNAc7dHex1               1062.466           4      1.2
                                                                                                                                          \$kDN(+3007.058)TTVTR                                                 N249        Known               Hex6HexNAc5dHex1NeuAc3         1098.476           4      4.4
                                                                                                                                          \$AAN(+1702.581)GSLR                                                  N322        Known               Hex8HexNAc2                    872.711            3      2.6
                                                                                                                                          \$AAN(+1864.634)GSLR                                                  N322        Known               Hex9HexNAc2                    926.395            3      3.5
  Lysosome-associated membrane glycoprotein 2                  LAMP2_HUMAN                                                                \$EkPEAGTYSVNNGN(+1054.370)DTcLLATmGLQLNITQDk                         N229        Known               Hex4HexNAc2                    1048.506           5      0.8
  Lysosomal alpha-glucosidase                                  LYAG_HUMAN                                                                 \$QVVEN(+1095.397)\^MTRAHFPLDVQWNDLDYMDSR                             N390        Known               Hex3HexNAc3                    905.408            5      0.9
                                                                                                                                          \$GAYTQVIFLARN(+1054.370)NTIVNELVR                                    N882        Known               Hex4HexNAc2                    918.718            4      1.4
  Protein-lysine 6-oxidase                                     LYOX_HUMAN                                                                 \$AEN(+1054.370)QTAPGEVPALSNLR                                        N144        Potential           Hex4HexNAc2                    762.369            4      8.1
                                                                                                                                          \$DPGAAVPGAANASAQQPRTPILLIRDN(+2432.884)R                             N97         Potential           Hex3HexNAc6dHex1NeuAc2         1106.316           5      −5.0
  Lymphatic vessel endothelial hyaluronic acid receptor 1      LYVE1_HUMAN                                                                \$AN(+1362.481)DSNPNEESkkTDk                                          N289        Novel               Hex5HexNAc2dHex1               984.727            4      5.8
  Lysosomal alpha-mannosidase                                  MA2B1_HUMAN                                                                \$GFkDHFTFcQQLN(+892.317)ISIcPLSQTAARFQVIVYnPLGRk                     N497        Potential           Hex3HexNAc2                    987.504            6      −1.2
  Hepatocyte growth factor receptor                            MET_HUMAN                                                                  \$TLLRN(+1751.624)\^SsGcEARRDEYR                                      N405        Potential           Hex4HexNAc4NeuAc1              1040.946           4      6.4
                                                               \$VIVQPDQN(+2042.720)\^\^FTGLIAGVVSISTALLLLLGFFLWLkkRk                     N930                                                                  Potential   Hex4HexNAc4NeuAc2   886.225                        8                  3.5    
                                                                                                                                          \$VIVQPDQN(+2174.799)\^FTGLIAGVVSISTALLLLLGFFLWLkkR                   N930        Potential           Hex5HexNAc6dHex1               1140.772           6      4.0
  Interstitial collagenase                                     MMP1_HUMAN                                                                 \$AFQLWSN(+2034.703)\^VTPLTFTk                                        N143        Novel               Hex7HexNAc3NeuAc1              1065.992           4      3.1
                                                                                                                                          \$AFQLWSN(+2059.735)VTPLTFTk                                          N143        Novel               Hex5HexNAc4dHex1NeuAc1         1065.999           4      0.3
                                                                                                                                          \$AFQLWSN(+2075.730)\^VTPLTFTk                                        N143        Novel               Hex6HexNAc4NeuAc1              1076.245           4      0.2
                                                                                                                                          \$AFQLWSN(+2075.730)VTPLTFTk                                          N143        Novel               Hex5HexNAc4dHex2NeuGc1         1070.250           4      1.4
                                                                                                                                          \$AFQLWSN(+2076.750)VTPLTFTk                                          N143        Novel               Hex6HexNAc4dHex2               1070.251           4      −1.0
                                                                                                                                          \$AFQLWSN(+2092.745)VTPLTFTk                                          N143        Novel               Hex7HexNAc4dHex2               1074.251           4      0.2
                                                                                                                                          \$AFQLWSN(+2350.830)\^VTPLTFTk                                        N143        Novel               Hex5HexNAc4dHex1NeuAc2         1144.769           4      −0.3
                                                                                                                                          \$AFQLWSN(+2350.830)VTPLTFTk                                          N143        Novel               Hex5HexNAc4dHex1NeuAc2         1139.021           4      −1.9
                                                                                                                                          \$AFQLWSN(+2351.851)VTPLTFTk                                          N143        Novel               Hex5HexNAc4dHex3NeuAc1         1139.277           4      −0.9
  Multimerin-1                                                 MMRN1_HUMAN                                                                \$INALkkPTVN(+1200.428)LTTVLIGR                                       N1020       Known               Hex4HexNAc2dHex1               957.031            4      1.5
                                                                                                                                          \$GARLFVLLSSLWSGGIGLN(+1241.455)\^NSk                                 N21         Potential           Hex3HexNAc3dHex1               1001.006           4      −3.0
                                                                                                                                          \$LFVLLSSLWSGGIGLN(+568.212)NSk                                       N21         Potential           Hex1HexNAc2                    756.162            4      −0.8
                                                                                                                                          \$IDN(+1095.397)\^ISLTVNDVRNTYSSLEGk                                  N344        Known               Hex3HexNAc3                    976.973            4      −1.1
                                                                                                                                          \$InN(+568.212)LTVSLEMEk                                              N576        Potential           Hex1HexNAc2                    803.746            3      −1.8
                                                                                                                                          \$kIEN(+892.317)LTSAVNSLNFIIk                                         N680        Potential           Hex3HexNAc2                    868.469            4      −3.4
                                                                                                                                          \$LNQSNFQkmYQMFN(+2262.815)\^ETTSQVR                                  N828        Potential           Hex5HexNAc5dHex1NeuAc1         1069.470           5      2.0
                                                                                                                                          \$ALEAkSIHLSInFFSLN(+568.212)k                                        N921        Potential           Hex1HexNAc2                    819.195            4      −5.2
                                                                                                                                          \$SIHLSINFFSLN(+892.318)\^k                                           N921        Potential           Hex3HexNAc2                    721.609            4      −6.7
  C-type mannose receptor 2                                    MRC2_HUMAN                                                                 [\$VTPAcN(+2059.735)TSLPAQR]{.ul}                                     N69         Known               Hex5HexNAc4dHex1NeuAc1         925.654            4      −2.1
                                                                                                                                          \$SN(+2059.735)VTk                                                    N954        Potential           Hex5HexNAc4dHex1NeuAc1         1020.122           3      0.2
  Nck-associated protein 5                                     NCKP5_HUMAN                                                                \$ERGPQGQGHGRMALNLQLSDTDDN(+2018.708)\^ETFDELHIESSDEk                 N585        Novel               Hex6HexNAc3dHex1NeuAc1         1127.492           6      −3.7
  Lysosomal protein NCU-G1                                     NCUG1_HUMAN                                                                \$LLHTADTcQLEVALIGAsPRGN(+1241.454)R                                  N230        Potential           Hex3HexNAc3dHex1               1010.223           4      −1.4
  Natural cytotoxicity triggering receptor 3 ligand 1          NR3L1_HUMAN                                                                \$LN(+2172.745)SSQEDPGTVYQcVVRHASLHTPLR                               N216        Potential           Hex10HexNAc2dHex1              1073.477           5      −4.3
  Neuronal cell adhesion molecule                              NRCAM_HUMAN                                                                \$IPAN(+2715.963)k                                                    N1009       Potential           Hex6HexNAc5dHex1NeuAc2         927.404            4      −1.4
                                                                                                                                          \$IPAN(+2960.068)\^\^k                                                N1009       Potential           Hex5HexNAc7dHex1NeuAc2         1000.181           4      6.5
                                                                                                                                          [\$FN(+1378.476)HTQTIQQk]{.ul}                                        N223        Potential           Hex6HexNAc2                    768.611            4      0.9
                                                                                                                                          [\$FN(+1378.476)HTQTIQQk]{.ul}                                        N223        Potential           Hex6HexNAc2                    1024.480           3      2.2
                                                                                                                                          \$SSRERPPTFLTPEGN(+1710.598)ASNk                                      N276        Known               Hex5HexNAc3NeuAc1              1062.994           4      −0.4
  Nuclear receptor-interacting protein 3                       NRIP3_HUMAN                                                                \$LMETN(+568.212)LSk                                                  N72         Novel               Hex1HexNAc2                    651.345            3      8.7
  Plasminogen activator inhibitor 1                            PAI1_HUMAN                                                                 \$GN(+1694.603)\^MTRLPRLLVLPkFSLETEVDLRk                              N288        Known               Hex4HexNAc3dHex1NeuAc1         1063.953           5      3.4
                                                                                                                                          \$GN(+2059.735)MTR                                                    N288        Known               Hex5HexNAc4dHex1NeuAc1         955.394            3      0.5
                                                                                                                                          \$GN(+2350.830)\^mTR                                                  N288        Known               Hex5HexNAc4dHex1NeuAc2         799.313            4      −3.7
                                                                                                                                          \$GN(+2351.851)\^mTR                                                  N288        Known               Hex5HexNAc4dHex3NeuAc1         798.814            4      −5.6
  Platelet-derived growth factor subunit B                     PDGFB_HUMAN                                                                \$LLHGDPGEEDGAELDLN(+1864.634)mTRSHSGGELESLARGRR                      N63         Novel               Hex9HexNAc2                    1176.921           5      −5.5
  Secretory phospholipase A2 receptor                          PLA2R_HUMAN                                                                \$MQDTSGHGVNTsDMYPMPNTLEYGN(+2204.772)\^\^RTYk                        N1123       Novel               Hex5HexNAc4NeuAc2              1014.913           6      −1.9
  Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2            PLOD2_HUMAN                                                                \$YFN(+1856.656)YTVkVLGQGEEWR                                         N63         Potential           Hex5HexNAc3dHex1NeuAc1         1074.744           4      0.2
  Phospholipid transfer protein                                PLTP_HUMAN                                                                 \$qLLYWFFYDGGYIN(+2157.783)\^ASAEGVSIRTGLELSR                         N117        Potential           Hex4HexNAc6NeuAc1              1118.898           5      0.2
                                                                                                                                          \$IYSN(+1403.507)HSALESLALIPLQAPLk                                    N398        Known               Hex4HexNAc3dHex1               1033.782           4      1.5
  Plexin-C1                                                    PLXC1_HUMAN                                                                \$IAN(+1524.534)\^FTSDVEYSDDHchLILPDSEAFQDVQGkRHR                     N1308       Novel               Hex6HexNAc2dHex1               1203.342           5      −1.8
                                                                                                                                          \$IAN(+2204.773)FTSDVEYSDDhcHLILPDSEAFQDVQGkR                         N1308       Novel               Hex5HexNAc4NeuAc2              638.689            10     5.9
                                                                                                                                          \$VILGEN(+1298.476)LTSNcPEVIYEIk                                      N407        Known               Hex3HexNAc4                    985.483            4      −1.8
                                                                                                                                          \$ELcQN(+1378.476)k                                                   N548        Potential           Hex6HexNAc2                    873.730            3      8.0
                                                                                                                                          \$DVcIQFDGGNcSSVGSLSYIALPHcSLIFPATTWISGGQN(+1403.508)\^ITMMGR         N771        Potential           Hex4HexNAc3dHex1               607.279            11     0.5
                                                                                                                                          \$ENDNFN(+1054.370)ISk                                                N871        Novel               Hex4HexNAc2                    861.725            3      −4.1
                                                                                                                                          \$ENDNFN(+2522.916)\^ISk                                              N871        Novel               Hex5HexNAc7NeuAc1              1019.438           4      7.5
  Tyrosine-protein kinase-like 7                               PTK7_HUMAN                                                                 [\$SAN(+3007.058)ASFNIk]{.ul}                                         N116        Known               Hex6HexNAc5dHex1NeuAc3         1102.722           4      2.1
                                                                                                                                          [\$SAN(+3026.090)ASFNIk]{.ul}                                         N116        Known               Hex9HexNAc7dHex1               1107.479           4      1.3
                                                                                                                                          \$ATVFAN(+1710.598)GSLLLTQVRPR                                        N283        Known               Hex5HexNAc3NeuAc1              945.458            4      0.0
                                                                                                                                          \$RQDVN(+1686.586)ITVATVPSWLk                                         N405        Potential           Hex7HexNAc2dHex1               991.485            4      3.2
  Pentraxin-related protein PTX3                               PTX3_HUMAN                                                                 \$ATDVLN(+1419.502)kTILFsYGTk                                         N220        Potential           Hex5HexNAc3                    986.474            4      −4.0
  Proactivator polypeptide                                     SAP_HUMAN                                                                  [\$TN(+1038.375)STFVQALVEHVk]{.ul}                                    N215        Known               Hex3HexNAc2dHex1               1020.847           3      1.2
                                                                                                                                          [\$LIDNN(+1216.423)kTEk]{.ul}                                         N332        Known               Hex5HexNAc2                    988.825            3      −0.7
                                                                                                                                          [\$LIDNN(+1378.476)kTEk]{.ul}                                         N332        Known               Hex6HexNAc2                    1042.510           3      0.7
                                                                                                                                          [\$LIDNN(+1694.603)kTEk]{.ul}                                         N332        Known               Hex4HexNAc3dHex1NeuAc1         861.415            4      −0.8
                                                                                                                                          \$N(+2245.800)\^STk                                                   N426        Known               Hex4HexNAc5NeuAc2              1056.113           3      −0.8
                                                                                                                                          \$NLEkN(+1378.476)STk                                                 N426        Known               Hex6HexNAc2                    995.485            3      2.5
  Histone deacetylase complex subunit SAP30                    SAP30_HUMAN                                                                \$N(+1095.397)kSDLk                                                   N209        Novel               Hex3HexNAc3                    824.751            3      −3.7
                                                               \$GGDAAAAVAAVVAAAAAAAsAGN(+1589.571)GTGAGTGAEVPGAGAVSAAGPPGAAGPGPGQLccLR   N34                                                                   Novel       Hex3HexNAc4NeuAc1   682.815                        10                 −0.7   
  Serpin H1                                                    SERPH_HUMAN                                                                \$SLSN(+1378.476)\^STAR                                               N120        Potential           Hex6HexNAc2                    821.017            3      −1.4
                                                                                                                                          \$SLSN(+1378.476)STAR                                                 N120        Potential           Hex6HexNAc2                    813.358            3      1.9
                                                                                                                                          \$SLSN(+1540.529)STAR                                                 N120        Potential           Hex7HexNAc2                    867.371            3      −3.6
                                                                                                                                          \$SLSN(+1702.581)STAR                                                 N120        Potential           Hex8HexNAc2                    922.062            3      1.6
                                                                                                                                          \$SLSN(+1864.634)STAR                                                 N120        Potential           Hex9HexNAc2                    975.414            3      4.5
                                                                                                                                          \$N(+1540.529)VTWk                                                    N125        Potential           Hex7HexNAc2                    879.399            3      −0.5
                                                                                                                                          \$N(+1702.581)VTWk                                                    N125        Potential           Hex8HexNAc2                    933.418            3      0.6
  Tyrosine-protein phosphatase non-receptor type substrate 1   SHPS1_HUMAN                                                                [\$LQLTWLEnGN(+1200.428)VSR]{.ul}                                     N292        Known               Hex4HexNAc2dHex1               739.847            4      −3.5
                                                                                                                                          [\$LQLTWLENGN(+1872.651)\^VSR]{.ul}                                   N292        Known               Hex6HexNAc3NeuAc1              912.893            4      −11.5
  SPARC                                                        SPRC_HUMAN                                                                 \$VcSNDN(+1622.582)k                                                  N116        Known               Hex5HexNAc4                    970.425            3      3.5
                                                                                                                                          \$VcSNDN(+1767.619)k                                                  N116        Known               Hex4HexNAc4NeuGc1              1019.107           3      4.9
                                                                                                                                          \$VcSNDN(+1768.640)k                                                  N116        Known               Hex5HexNAc4dHex1               1018.439           3      0.0
                                                                                                                                          \$VcSNDN(+1864.634)k                                                  N116        Known               Hex9HexNAc2                    1051.108           3      2.2
                                                                                                                                          \$VcSNDN(+1913.677)\^k                                                N116        Known               Hex5HexNAc4NeuAc1              806.336            4      −1.4
                                                                                                                                          \$VcSNDN(+1913.677)k                                                  N116        Known               Hex5HexNAc4NeuAc1              800.591            4      −0.3
                                                                                                                                          \$VcSNDN(+1913.677)k                                                  N116        Known               Hex5HexNAc4NeuAc1              1066.783           3      −1.7
                                                                                                                                          \$VcSNDN(+1914.697)k                                                  N116        Known               Hex5HexNAc4dHex2               800.844            4      −2.5
                                                                                                                                          \$VcSNDN(+1914.697)k                                                  N116        Known               Hex5HexNAc4dHex2               1067.125           3      0.6
                                                                                                                                          \$VcSNDN(+2059.735)\^k                                                N116        Known               Hex5HexNAc4dHex1NeuAc1         842.598            4      −3.0
                                                                                                                                          \$VcSNDN(+2059.735)k                                                  N116        Known               Hex5HexNAc4dHex1NeuAc1         836.857            4      3.1
                                                                                                                                          \$VcSNDN(+2059.735)k                                                  N116        Known               Hex5HexNAc4dHex1NeuAc1         1115.472           3      1.6
                                                                                                                                          \$VcSNDN(+2350.830)k                                                  N116        Known               Hex5HexNAc4dHex1NeuAc2         909.629            4      0.3
  Stabilin-1                                                   STAB1_HUMAN                                                                \$ELLQHHGLVPQIEAATAYTIFVPTnRSLEAQGN(+2366.825)\^SSHLDADTVR            N1178       Potential           Hex6HexNAc4NeuAc2              732.443            10     3.2
                                                                                                                                          \$ELkGDGPFTIFVPHADLMSN(+568.212)LSQDELARIR                            N1626       Known               Hex1HexNAc2                    1097.310           4      −5.4
                                                                                                                                          \$LLPAHsGLSLIISDAGPDN(+892.317)SSWAPVAPGTVVVSR                        N2424       Known               Hex3HexNAc2                    655.464            7      −7.8
                                                                                                                                          \$ILTMAnQVLAVN(+1095.397)ISEEGR                                       N606        Potential           Hex3HexNAc3                    820.390            4      −9.4
                                                                                                                                          \$GN(+1216.423)cSDGIQGNGAcLcFPDYk                                     N745        Potential           Hex5HexNAc2                    975.155            4      −10.2
  Suppressor of G2 allele of SKP1 homolog                      SUGT1_HUMAN                                                                \$RAMN(+568.212)kSFMESGGTVLSTNWsDVGk                                  N329        Novel               Hex1HexNAc2                    981.480            4      6.2
  Angiopoietin-1 receptor                                      TIE2_HUMAN                                                                 \$ISN(+568.212)ITHSSAVIsWTILDGYSISSITIR                               N649        Potential           Hex1HexNAc2                    762.382            5      −3.1
  Tetraspanin-3                                                TSN3_HUMAN                                                                 \$TYN(+1825.661)GTNPDAASRAIDYVQR                                      N127        Potential           Hex5HexNAc5                    1041.454           4      −7.9
  Thrombospondin-1                                             TSP1_HUMAN                                                                 [\$VVN(+1913.677)STTGPGEHLR]{.ul}                                     N1067       Known               Hex5HexNAc4NeuAc1              877.141            4      0.2
  Vascular endothelial growth factor receptor 1                VGFR1_HUMAN                                                                \$RIIWDSRkGFIISN(+892.317)ATYk                                        N196        Potential           Hex3HexNAc2                    934.508            4      8.1
                                                               \$SVN(+892.318)TSVhIYDkAFITVk                                              N323                                                                  Potential   Hex3HexNAc2         876.466                        4                  10.2   
                                                                                                                                          \$WFWHPcNHN(+1419.502)HSEARcDFcSNNEESFILDADSnMGNR                     N474        Potential           Hex5HexNAc3                    1017.415           6      1.3
                                                                                                                                          \$mAITkEhSITLNLTIMN(+1257.450)\^VSLQDSGTYAcRAR                        N625        Potential           Hex4HexNAc3                    1051.702           5      −0.2
  von Willebrand factor                                        VWF_HUMAN                                                                  \$YFN(+2059.735)\^k                                                   N156        Potential           Hex5HexNAc4dHex1NeuAc1         776.330            4      −4.7
                                                                                                                                          \$YFN(+2059.735)\^k                                                   N156        Potential           Hex5HexNAc4dHex1NeuAc1         1034.440           3      −1.2
                                                                                                                                          \$YFN(+2059.735)k                                                     N156        Potential           Hex5HexNAc4dHex1NeuAc1         1027.114           3      −0.1
                                                                                                                                          \$YFN(+2059.736)k                                                     N156        Potential           Hex5HexNAc4dHex1NeuAc1         770.587            4      −0.6
                                                                                                                                          \$YFN(+2204.772)k                                                     N156        Potential           Hex5HexNAc4NeuAc2              1075.798           3      3.0
                                                                                                                                          \$YFN(+2221.789)k                                                     N156        Potential           Hex6HexNAc4dHex1NeuAc1         1081.467           3      0.8
                                                                                                                                          \$YFN(+2350.830)\^\^k                                                 N156        Potential           Hex5HexNAc4dHex1NeuAc2         854.851            4      −3.2
                                                                                                                                          \$YFN(+2350.830)\^k                                                   N156        Potential           Hex5HexNAc4dHex1NeuAc2         848.856            4      −0.9
                                                                                                                                          \$YFN(+2350.830)\^k                                                   N156        Potential           Hex5HexNAc4dHex1NeuAc2         1131.473           3      −0.2
                                                                                                                                          \$YFN(+2350.830)k                                                     N156        Potential           Hex5HexNAc4dHex1NeuAc2         843.362            4      0.5
                                                                                                                                          \$YFN(+2350.830)k                                                     N156        Potential           Hex5HexNAc4dHex1NeuAc2         1124.145           3      −0.7
                                                                                                                                          \$YFN(+2350.831)\^k                                                   N156        Potential           Hex5HexNAc4dHex1NeuAc2         848.857            4      0.0
                                                                                                                                          \$YFN(+2350.831)k                                                     N156        Potential           Hex5HexNAc4dHex1NeuAc2         843.362            4      1.2
                                                                                                                                          \$YFN(+2351.851)\^k                                                   N156        Potential           Hex5HexNAc4dHex3NeuAc1         849.613            4      −0.2
                                                                                                                                          \$YFN(+2366.825)\^k                                                   N156        Potential           Hex5HexNAc4dHex1NeuAc1NeuGc1   853.098            4      −9.4
                                                                                                                                          \$YFN(+2366.825)k                                                     N156        Potential           Hex5HexNAc4dHex1NeuAc1NeuGc1   1129.813           3      0.5
                                                                                                                                          \$YFN(+2715.963)\^k                                                   N156        Potential           Hex6HexNAc5dHex1NeuAc2         940.387            4      −3.7
                                                                                                                                          \$YFN(+2715.963)k                                                     N156        Potential           Hex6HexNAc5dHex1NeuAc2         934.643            4      −0.8
                                                                                                                                          \$YFN(+2716.983)k                                                     N156        Potential           Hex6HexNAc5dHex3NeuAc1         934.898            4      −1.5
                                                                                                                                          \$YFN(+2861.001)k                                                     N156        Potential           Hex6HexNAc5NeuAc3              971.409            4      3.7
                                                                                                                                          \$YFN(+3007.058)k                                                     N156        Potential           Hex6HexNAc5dHex1NeuAc3         1007.667           4      −2.2
                                                                                                                                          \$YFN(+3009.074)k                                                     N156        Potential           Hex8HexNAc7                    1007.923           4      0.6
                                                                                                                                          \$YFN(+3026.089)k                                                     N156        Potential           Hex9HexNAc7dHex1               1012.676           4      −2.0
                                                                                                                                          \$YFN(+3372.190)k                                                     N156        Potential           Hex7HexNAc6dHex1NeuAc3         1098.951           4      −0.9
                                                                                                                                          \$GDILQRVREIRYQGGN(+1378.476)R                                        N1574       Known               Hex6HexNAc2                    909.439            4      −0.2
                                                                                                                                          \$GDILQRVREIRYQGGN(+568.212)RTNTGLALR                                 N1574       Known               Hex1HexNAc2                    912.984            4      −4.0
                                                                                                                                          \$YQGGN(+2059.735)R                                                   N1574       Known               Hex5HexNAc4dHex1NeuAc1         993.411            3      1.2
                                                                                                                                          [\$ASPPSSScN(+2059.735)ISSGEmQk]{.ul}                                 N211        Potential           Hex5HexNAc4dHex1NeuAc1         1073.955           4      −2.4
                                                                                                                                          [\$ASPPSSScN(+2350.830)\^ISSGEmQk]{.ul}                               N211        Potential           Hex5HexNAc4dHex1NeuAc2         1151.736           4      8.9
                                                                                                                                          [\$ASPPSSScN(+2350.830)ISSGEmQk]{.ul}                                 N211        Potential           Hex5HexNAc4dHex1NeuAc2         1146.231           4      0.3
                                                                                                                                          \$N(+2059.735)VScPQLEVPVcPSGFQLSck                                    N2546       Known               Hex5HexNAc4dHex1NeuAc1         984.037            5      −3.6
                                                                                                                                          [\$GQVYLQcGTPcN(+2059.735)LTcR]{.ul}                                  N666        Potential           Hex5HexNAc4dHex1NeuAc1         1053.444           4      0.9
                                                                                                                                          [\$GQVYLQcGTPcN(+2075.730)LTcR]{.ul}                                  N666        Potential           Hex6HexNAc4NeuAc1              1057.695           4      2.2
                                                                                                                                          [\$GQVYLQcGTPcN(+2076.750)LTcR]{.ul}                                  N666        Potential           Hex6HexNAc4dHex2               1058.193           4      −0.6
                                                                                                                                          [\$GQVYLQcGTPcN(+2350.830)LTcR]{.ul}                                  N666        Potential           Hex5HexNAc4dHex1NeuAc2         1126.222           4      4.5
  Bovine proteins                                                                                                                                                                                                                                                                                        
      Alpha-1-acid glycoprotein                                A1AG_BOVIN                                                                 \$QN(+2861.000)\^GTLSk                                                N104        Potential           Hex6HexNAc5NeuAc3              1020.428           4      0.4
                                                                                                                                          \$QN(+2861.000)GTLSk                                                  N104        Potential           Hex6HexNAc5NeuAc3              1014.934           4      1.8
                                                                                                                                          \$QN(+2880.031)GTLSk                                                  N104        Potential           Hex9HexNAc7                    1019.690           4      0.5
                                                                                                                                          \$NPEYN(+2814.010)\^\^k                                               N57         Potential           Hex5HexNAc7NeuAc2              1018.923           4      6.2
      Alpha-fetoprotein                                        FETA_BOVIN                                                                 [\$AEN(+1200.428)ATEcFETk]{.ul}                                       N197        Potential           Hex4HexNAc2dHex1               983.428            3      −5.8
                                                                                                                                          [\$AEN(+2204.772)ATEcFETk]{.ul}                                       N197        Potential           Hex5HexNAc4NeuAc2              988.913            4      0.1
                                                                                                                                          [\$AN(+2204.772)FTEIQk]{.ul}                                          N251        Potential           Hex5HexNAc4NeuAc2              901.651            4      2.5
      Alpha-2-HS-glycoprotein                                  FETUA_BOVIN                                                                [\$kLcPDcPLLAPLN(+2204.772)DSR]{.ul}                                  N156        Known               Hex5HexNAc4NeuAc2              905.409            5      0.3
                                                                                                                                          [\$kLcPDcPLLAPLN(+2861.000)DSR]{.ul}                                  N156        Known               Hex6HexNAc5NeuAc3              1036.654           5      −1.0
                                                                                                                                          [\$LcPDcPLLAPLN(+2204.772)DSR]{.ul}                                   N156        Known               Hex5HexNAc4NeuAc2              1043.195           4      −1.7

Peptide modification symbols: \$, N-terminal TMT0 labelling (+224.152); \^, Na adduct on glycan (+21.982); \^\^, 2 Na adduct on glycan (+43.964); c, carbamidomethylation of cysteine (+57.021); h, oxidation of histidine (+15.995); k, TMT^0^ labeling of lysine (+224.152); m, oxidation of methionine (+15.995); n, deamidation of asparagine (+0.984); q, Gln-\>pyro-Glu and loss of TMT^0^ (−241.179); s, phosphorylation of serine (+79.966).

Underlined glycopeptides were also detected via the PNGase F + H~2~^18^O method ([supplemental Table S4](http://www.mcponline.org/cgi/content/full/M112.024018/DC1)).

![**HCD-pd-ETD fragmentation.** Full MS showing the different glycoforms of the same peptide sequence *(A)*. Characteristic oxonium ion detected by HCD at m/z = 204.09 *(B)*. This HexNAc signature triggered an ETD scan to identify the peptide sequence and confirm the glycosylation site *(C)*.](zjw0041344130003){#F3}

For the same samples, HCD-pd-ETD revealed 28 known, 25 potential, and 16 novel glycosylation sites based on 209 identified spectra; HCD-alt-ETD revealed 20 known, 32 potential, and 14 novel glycosylation sites from 110 identified spectra. The HCD-alt-ETD method selected mostly precursors with higher intensities, higher charge, and smaller *m*/*z* ([Fig. 4](#F4){ref-type="fig"}*A*). Several large glycopeptides were detected via only HCD-alt-ETD, and more low-abundant glycopeptides were detected via HCD-pd-ETD. There was limited overlap in the identified glycopeptides but better agreement in the protein level ([Fig. 4](#F4){ref-type="fig"}*B*). Among the 319 total glycopeptides identified in the conditioned media, 31 were attached with a trimannosyl core (-HexNAc~2~Hex~3~) or truncated core (-HexNAc~2~Hex), 50 with high mannose (-HexNAc~2~Hex~4--9~), and 238 with complex/hybrid glycans. Notably, HCD-pd-ETD detected almost twice as many complex/hybrid glycoforms as HCD-alt-ETD ([Fig. 4](#F4){ref-type="fig"}*C*).

![**Comparison of HCD-pd-ETD and HCD-alt-ETD.** The two methods, HCD-pd-ETD (blue) and HCD-alt-ETD (red), displayed distinct distributions of the observed *m*/*z*, charge state, mass of identified peptides (M+H), and glycan mass, as well as the intensity of the precursor ions and the Byonics^TM^ score (all *y*-axes). The *x*-axes represent index numbers after proteins were sorted by their corresponding *y*-axis value from lower to higher (*A*). There was limited overlap in the identified glycopeptides (*B*). *C*, the HCD-pd-ETD method preferentially identified complex/hybrid glycans.](zjw0041344130004){#F4}

#### Validation of Glycoproteins

To validate the glycosylation status, we performed additional analysis before and after glycoprotein enrichment with affinity resins of ConA lectin (*n* = 4) using a Q Exactive MS (Thermo Scientific). We then compared the number of identified spectra in the glycoprotein-enriched fraction, the flow-through, and the input ([supplemental Table S5](http://www.mcponline.org/cgi/content/full/M112.024018/DC1)). For most glycoproteins, a higher spectral count was observed in the glycoprotein-enriched fraction than in the original input and/or the flow-through. Representative examples (fibronectin, neuronal cell adhesion molecule, tyrosine-protein-kinase-like 7, and vWF) are shown in [Fig. 5](#F5){ref-type="fig"}*A*. Non-glycosylated proteins, such as annexin A2 and alpha-enolase, were more abundant in the flow-through. Glycoproteins identified in all three methods are highlighted in [Fig. 5](#F5){ref-type="fig"}*B*.

![**Glycoprotein enrichment for validation.** *A*, spectral count of input, glycoprotein-enriched fraction (GP), and flow-through fraction (FT) from representative glycoproteins and non-glycoproteins. *B*, complementarity of the different methods (HCD-ETD, PNGase F + H~2~^18^O treatment, and glycoprotein enrichment). Only 18 glycoproteins were consistently identified.](zjw0041344130005){#F5}

#### Confirmation of Predicted Glycosylation Sites

The hemostatic protein vWF is the main protein stored within Weibel-Palade bodies ([@B27]). After secretagogue stimulation, Weibel-Palade bodies undergo exocytosis, releasing vWF filaments. vWF is one of the few known proteins containing the ABO blood group signature, which is formed by different glycans. Although the released glycan composition of this protein has been investigated extensively ([@B28], [@B29]), experimental evidence for many putative glycosylation sites is still missing. The coverage obtained for vWF in our proteomics analysis is shown in [Fig. 6](#F6){ref-type="fig"}*A*. The precursor protein consists of homologous units such as the VWF type A, C, and D domains and a C-terminal cystine know (CTCK). The vWF propeptide (D1-D2, AA 23--763) is separated from the remaining domains of mature vWF (AA 764--2813) via furin-mediated proteolytic cleavage. We confirmed 6 N-glycosylation sites. Notably, three N-glycosylation sites were located within the propeptide (AA 23--763). Examples of ETD spectra are shown in [Fig. 6](#F6){ref-type="fig"}*B*.

![**Sequence coverage for vWF.** *A*, schematic illustration of vWF sequence. Coverage is highlighted in green, and potential glycosylation sites are shown in red. A large hexagon indicates a glycosylation site with a reference in the Uniprot database. By using the HCD-ETD (H) or PNGase F (P) method, we confirmed six N-glycosylation sites on vWF. *B*, ETD spectra of glycopeptides identified via HCD-ETD (N156, N211, N666, N1574). The following abbreviations are used: a, y, g, k = TMT modified Ala, Tyr, Gly, and Lys, respectively; c = carboxyamidomethylation of Cys; m = oxidation of Met.](zjw0041344130006){#F6}

DISCUSSION
==========

This study represents a significant advance over the existing proteomics literature on ECs. Unlike other cell types, ECs do not tolerate prolonged serum starvation, and their susceptibility to cell death upon serum withdrawal poses a major challenge for proteomic workflows targeting their secretome. We performed secretome analysis after 45 min of PMA stimulation combined with enrichment strategies for glycoproteins and glycopeptides. Glycopeptides were analyzed via three complementary MS techniques: the detection of ^18^O asparagine deamidation after digestion with PNGase F in H~2~^18^O, HCD-alt-ETD, and HCD-pd-ETD using an Orbitrap Elite MS.

### 

#### The Endothelial Secretome

The secretagogue PMA minimized EC death by allowing a shorter incubation period under serum-free conditions while increasing coverage in the proteomic analysis by inducing the exocytosis of intracellular storage vesicles ([@B14]) such as Weibel-Palade bodies. These unique storage vesicles in ECs play a major role in hemostasis and cell-to-cell communication. Using this approach, many more proteins were identified than in any previous proteomics study on ECs, including known endothelial surface markers such as endoglin (CD105), integrin beta-1 (CD29), tyrosine-protein kinase receptor Tie-1, and junctional adhesion molecule A; secreted growth factors (*i.e.* C-type lectin domain family 11 member A); co-receptors (*i.e.* neuropilin-1 (co-receptor for VEGF-A)); proteases(*i.e.* furin); and inflammatory mediators (*i.e.* macrophage migration inhibitory factor), to name just a few. Short-term PMA treatment does not release microparticles ([@B30]), as shedding events make it difficult to discern intracellular from secreted/membrane proteins. In a direct comparison of the cellular proteome and the secretome utilizing difference gel electrophoresis, 70 out of 96 proteins analyzed were present in both samples, representing \<10% of the visible protein spots in the secretome.

#### Biological Importance of Glycosylation

Glycosylation is key for the stability and solubility of secreted and membrane proteins. It is the most complex post-translational modification ([@B31]) and mediates extracellular matrix network assembly, cell--cell interactions, and cell--matrix interactions. Unlike polynucleotides and polypeptides, which have a linear structure, sugars tend to be arranged in branched polymers, resulting in an exponential increase of possible polysaccharide combinations. Theoretically, just six monosaccharides can give rise to 10^12^ different glycan structures. This high diversity of protein-bound glycans requires a combination of different techniques. For example, new MS-based methods were developed to profile the cell surface N-glycoproteome as a differentiation marker for stem cells ([@B32]). We applied a combination of different glycoproteomics techniques to further enrich for secreted and shed membrane proteins and reveal potential glycosylation sites within the endothelial secretome. Glycoproteins play important roles in many biological processes related to ECs, such as angiogenesis, in which the structural change of the glycans will determine the attachment property of cells and influence cell-to-cell interactions ([@B33]). Interestingly, vWF is a glycoprotein produced uniquely by ECs and megakaryocytes. Previous publications investigating vWF isolated from plasma failed to identify glycosylation sites within the propeptide ([@B29]). In plasma, the concentration of the propeptide is about one-tenth of the concentration of mature vWF ([@B34], [@B35]). In the conditioned medium of ECs, however, we observed several glycopeptides of the propeptide. Thus, the endothelial secretome allowed us to interrogate the glycosylation sites of von Willebrand antigen 2, the N-terminal cleavage product of vWF that aids N-terminal multimerization and protein compartmentalization of mature vWF in storage granules.

#### Conventional Methods for Glycoproteomics

As reviewed elsewhere ([@B36]), conventional glycoproteomic methods involve the enrichment of glycoproteins (typically with lectins like ConA and wheat germ agglutinin), cleavage of the glycans, and identification of the remaining peptide sequence. The most widely used method for detecting N-glycopeptides is digestion by PNGase F. PNGase F cleaves the GlcNAc molecule closest to the peptide ([@B37]). After PNGase F treatment, formerly *N*-linked glycosylated peptides are identified based on the conversion of Asn to Asp (deamidation) in the consensus motif for *N*-linked glycosylation (sequence N-X(not P)-S/T). This method has two major caveats. The first of these is a high false positive rate due to spontaneous deamidation. Asn-Gly sites, in particular, are prone to spontaneous deamidation ([@B38][@B39]--[@B40]). To reduce false positives, PNGase F treatment is performed in ^18^O water, adding a larger tag of 2.99 Da. Importantly, all known glycosyltransferases that mediate *N*-linked glycosylation are supposed to recognize a consensus motif, and this consensus sequence for *N*-linked glycosylation must be taken into consideration ([@B41]). 2) The second caveat is that after PNGase F cleavage, the released sugars can be analyzed separately, but the link to the identified peptides with deamidated amino acids is lost ([@B42], [@B43]). Ideally, intact glycopeptides are analyzed directly via MS/MS even in complex biological samples.

#### Novel HCD-ETD Method

HCD fragmentation mostly breaks glycosidic bonds, whereas ETD preserves the glycan attachment and fragments the peptide backbone, providing more complete peptide sequence information. Current MS/MS acquisition strategies for glycopeptide analysis rely on the acquisition of MS/MS spectra for all precursor ions. In this study, HCD was employed to generate glycan oxonium ions and trigger an ETD spectrum in a data-dependent manner. HCD presents the sugar signatures within the low *m*/*z* range, which are otherwise lost as a result of the one-third rule of ion trap fragmentation ([@B44]). Glycopeptides with terminal HexNAc generate typically an *m*/*z* 204.0864 oxonium ion and its fragments at *m*/*z* 168.0653 and 138.0550. The oxonium ion and its fragments are measured with the high mass accuracy of the Orbitrap analyzer, and the unambiguous identification of the glycan oxonium ion generated by the HCD scan serves as a diagnostic marker for glycopeptides. This approach was compared against conventional HCD-alt-ETD scans using a complex biological sample. The HCD-alt-ETD preferentially detects higher charged and higher intensity precursor ions than HCD-pd-ETD. This might be because (i) a higher charge increases ETD fragmentation efficiency, resulting in more identified glycopeptides; (ii) high-charged precursors did not produce HCD spectra of sufficient quality to trigger ETD based on the diagnostic oxonium ions; or (iii) more abundant peptides were selected in HCD-alt-ETD because the instrument duty cycle is less efficient than in HCD-pd-ETD. Overall, the combination of multiple MS methods used in our study provides greater confidence in the identification of glycopeptides than studies relying on a single approach and offers complementary advantages in the assessment of the glycoproteome, notably, the simultaneous identification of the peptide sequence, the glycosylation site, and the glycan composition.

#### Study Limitations

*N*-linked and O-linked glycosylation are the two most common forms of glycosylation in mammals ([@B45]). Only *N*-linked glycosylation was analyzed in the present study. Unlike *N*-linked glycosylation, O-linked glycosylation has no consensus site ([@B46]). This makes the analysis of O-linked glycopeptides a more daunting task ([@B47]). Lectins are widely used for glycoprotein enrichment. There are many types of lectins binding to different sugars, such as ConA (binds to α-[d]{.smallcaps}-mannosyl and α-[d]{.smallcaps}-glucosyl residues) and wheat germ agglutinin (binds to GlcNAcβ1--4GlcNAcβ1--4GlcNAc- and N-acetylneuraminic acid). Here we used only ConA as a proof of principle to demonstrate the complementary results of multiple glycoprotein identification methods. ConA is known to display nonspecific avidity for hydrophobic ligands such as certain domains of tropomyosin ([@B48]). Furthermore, the standard protocol for the ConA glycoprotein enrichment kit is not optimized for cleanliness, and several known non-glycoproteins were also detected in the eluate samples. Sequential washes with low- and high-ionic-strength buffers before elution might have reduced this contamination ([@B49]). Also, mixing different lectins would increase the coverage of the glycoproteome in biological samples ([@B39]). Additional efforts are needed for a complete structural characterization of protein glycosylation; in particular, the quantitation of the occupancy rates and the identification of the glycan structure as complex/hybrid glycans cannot be discerned via our current MS approach.

CONCLUSIONS
===========

Cardiovascular diseases arise from exposure to risk factors that induce complex pathophysiological perturbations of endothelial protein secretion. The recent advent of new proteomic technologies has enabled us to obtain information on the dynamic regulation of endothelial protein secretion. We present results from an extensive glycoproteomic analysis with information on glycan composition obtained via a direct MS method. Future proteomics studies linking endothelial secretory processes to cardiovascular risk factors and endothelial dysfunction will provide valuable insights about the mechanisms contributing to cardiovascular disease.
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We thank Dr. Sarah Langley for assistance with the gene ontology annotation.
